Florida Statute 893.3 - Full Text and Legal Analysis

The 2025 Florida Statutes

Title XLVI
CRIMES

Chapter 893
DRUG ABUSE PREVENTION AND CONTROL

View Entire Chapter

F.S. 893.03

893.03 Standards and schedules.—The substances enumerated in this section are controlled by this chapter. The controlled substances listed or to be listed in Schedules I, II, III, IV, and V are included by whatever official, common, usual, chemical, trade name, or class designated. The provisions of this section shall not be construed to include within any of the schedules contained in this section any excluded drugs listed within the purview of 21 C.F.R. s. 1308.22, styled “Excluded Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt Anabolic Steroid Products.”

(1) SCHEDULE I.—A substance in Schedule I has a high potential for abuse and has no currently accepted medical use in treatment in the United States and in its use under medical supervision does not meet accepted safety standards. The following substances are controlled in Schedule I:

(a) Unless specifically excepted or unless listed in another schedule, any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

1. Acetyl-alpha-methylfentanyl.

2. Acetylmethadol.

3. Allylprodine.

4. Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM).

5. Alphamethadol.

6. Alpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine).

7. Alpha-methylthiofentanyl.

8. Alphameprodine.

9. Benzethidine.

10. Benzylfentanyl.

11. Betacetylmethadol.

12. Beta-hydroxyfentanyl.

13. Beta-hydroxy-3-methylfentanyl.

14. Betameprodine.

15. Betamethadol.

16. Betaprodine.

17. Clonitazene.

18. Dextromoramide.

19. Diampromide.

20. Diethylthiambutene.

21. Difenoxin.

22. Dimenoxadol.

23. Dimepheptanol.

24. Dimethylthiambutene.

25. Dioxaphetyl butyrate.

26. Dipipanone.

27. Ethylmethylthiambutene.

28. Etonitazene.

29. Etoxeridine.

30. Flunitrazepam.

31. Furethidine.

32. Hydroxypethidine.

33. Ketobemidone.

34. Levomoramide.

35. Levophenacylmorphan.

36. Desmethylprodine (1-Methyl-4-Phenyl-4-Propionoxypiperidine).

37. 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide).

38. 3-Methylthiofentanyl.

39. Morpheridine.

40. Noracymethadol.

41. Norlevorphanol.

42. Normethadone.

43. Norpipanone.

44. Para-Fluorofentanyl.

45. Phenadoxone.

46. Phenampromide.

47. Phenomorphan.

48. Phenoperidine.

49. PEPAP (1-(2-Phenylethyl)-4-Phenyl-4-Acetyloxypiperidine).

50. Piritramide.

51. Proheptazine.

52. Properidine.

53. Propiram.

54. Racemoramide.

55. Thenylfentanyl.

56. Thiofentanyl.

57. Tianeptine.

58. Tilidine.

59. Trimeperidine.

60. Acetylfentanyl.

61. Butyrylfentanyl.

62. Beta-Hydroxythiofentanyl.

63. Fentanyl derivatives. Unless specifically excepted, listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations containing a 4-anilidopiperidine structure:

a. With or without substitution at the carbonyl of the aniline moiety with alkyl, alkenyl, carboalkoxy, cycloalkyl, methoxyalkyl, cyanoalkyl, or aryl groups, or furanyl, dihydrofuranyl, benzyl moiety, or rings containing heteroatoms sulfur, oxygen, or nitrogen;

b. With or without substitution at the piperidine amino moiety with a phenethyl, benzyl, alkylaryl (including heteroaromatics), alkyltetrazolyl ring, or an alkyl or carbomethoxy group, whether or not further substituted in the ring or group;

c. With or without substitution or addition to the piperdine ring to any extent with one or more methyl, carbomethoxy, methoxy, methoxymethyl, aryl, allyl, or ester groups;

d. With or without substitution of one or more hydrogen atoms for halogens, or methyl, alkyl, or methoxy groups, in the aromatic ring of the anilide moiety;

e. With or without substitution at the alpha or beta position of the piperidine ring with alkyl, hydroxyl, or methoxy groups;

f. With or without substitution of the benzene ring of the anilide moiety for an aromatic heterocycle; and

g. With or without substitution of the piperidine ring for a pyrrolidine ring, perhydroazepine ring, or azepine ring;

excluding, Alfentanil, Carfentanil, Fentanyl, and Sufentanil; including, but not limited to:

(I) Acetyl-alpha-methylfentanyl.

(II) Alpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine).

(III) Alpha-methylthiofentanyl.

(IV) Benzylfentanyl.

(V) Beta-hydroxyfentanyl.

(VI) Beta-hydroxy-3-methylfentanyl.

(VII) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide).

(VIII) 3-Methylthiofentanyl.

(IX) Para-Fluorofentanyl.

(X) Thenylfentanyl or Thienyl fentanyl.

(XI) Thiofentanyl.

(XII) Acetylfentanyl.

(XIII) Butyrylfentanyl.

(XIV) Beta-Hydroxythiofentanyl.

(XV) Lofentanil.

(XVI) Ocfentanil.

(XVII) Ohmfentanyl.

(XVIII) Benzodioxolefentanyl.

(XIX) Furanyl fentanyl.

(XX) Pentanoyl fentanyl.

(XXI) Cyclopentyl fentanyl.

(XXII) Isobutyryl fentanyl.

(XXIII) Remifentanil.

64. Nitazene derivatives. Unless specifically excepted, listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations containing a benzimidazole ring with an ethylamine substitution at the 1-position and a benzyl ring substitution at the 2-position structure:

a. With or without substitution on the benzimidazole ring with alkyl, alkoxy, carboalkoxy, amino, nitro, or aryl groups, or halogens;

b. With or without substitution at the ethylamine amino moiety with alkyl, dialkyl, acetyl, or benzyl groups, whether or not further substituted in the ring system;

c. With or without inclusion of the ethylamine amino moiety in a cyclic structure;

d. With or without substitution of the benzyl ring; or

e. With or without replacement of the benzyl ring with an aromatic ring, including, but not limited to:

(I) Butonitazene.

(II) Clonitazene.

(III) Etodesnitazene.

(IV) Etonitazene.

(V) Flunitazene.

(VI) Isotodesnitazene.

(VII) Isotonitazene.

(VIII) Metodesnitazene.

(IX) Metonitazene.

(X) Nitazene.

(XI) N-Desethyl Etonitazene.

(XII) N-Desethyl Isotonitazene.

(XIII) N-Piperidino Etonitazene.

(XIV) N-Pyrrolidino Etonitazene.

(XV) Protonitazene.

(b) Unless specifically excepted or unless listed in another schedule, any of the following substances, their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. Acetorphine.

2. Acetyldihydrocodeine.

3. Benzylmorphine.

4. Codeine methylbromide.

5. Codeine-N-Oxide.

6. Cyprenorphine.

7. Desomorphine.

8. Dihydromorphine.

9. Drotebanol.

10. Etorphine (except hydrochloride salt).

11. Heroin.

12. Hydromorphinol.

13. Methyldesorphine.

14. Methyldihydromorphine.

15. Monoacetylmorphine.

16. Morphine methylbromide.

17. Morphine methylsulfonate.

18. Morphine-N-Oxide.

19. Myrophine.

20. Nicocodine.

21. Nicomorphine.

22. Normorphine.

23. Pholcodine.

24. Thebacon.

(c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following hallucinogenic substances or that contains any of their salts, isomers, including optical, positional, or geometric isomers, homologues, nitrogen-heterocyclic analogs, esters, ethers, and salts of isomers, homologues, nitrogen-heterocyclic analogs, esters, or ethers, if the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation or class description:

1. Alpha-Ethyltryptamine.

2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2-oxazoline).

3. Aminorex (2-Amino-5-phenyl-2-oxazoline).

4. DOB (4-Bromo-2,5-dimethoxyamphetamine).

5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).

6. Bufotenine.

7. Cannabis.

8. Cathinone.

9. DET (Diethyltryptamine).

10. 2,5-Dimethoxyamphetamine.

11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).

12. DMT (Dimethyltryptamine).

13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine analog of phencyclidine).

14. JB-318 (N-Ethyl-3-piperidyl benzilate).

15. N-Ethylamphetamine.

16. Fenethylline.

17. 3,4-Methylenedioxy-N-hydroxyamphetamine.

18. Ibogaine.

19. LSD (Lysergic acid diethylamide).

20. Mescaline.

21. Methcathinone.

22. 5-Methoxy-3,4-methylenedioxyamphetamine.

23. PMA (4-Methoxyamphetamine).

24. PMMA (4-Methoxymethamphetamine).

25. DOM (4-Methyl-2,5-dimethoxyamphetamine).

26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).

27. MDA (3,4-Methylenedioxyamphetamine).

28. JB-336 (N-Methyl-3-piperidyl benzilate).

29. N,N-Dimethylamphetamine.

30. Parahexyl.

31. Peyote.

32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine analog of phencyclidine).

33. Psilocybin.

34. Psilocyn.

35. Salvia divinorum, except for any drug product approved by the United States Food and Drug Administration which contains Salvia divinorum or its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, if the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation.

36. Salvinorin A, except for any drug product approved by the United States Food and Drug Administration which contains Salvinorin A or its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, if the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation.

37. Xylazine.

38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine) (Thiophene analog of phencyclidine).

39. 3,4,5-Trimethoxyamphetamine.

40. Methylone (3,4-Methylenedioxymethcathinone).

41. MDPV (3,4-Methylenedioxypyrovalerone).

42. Methylmethcathinone.

43. Methoxymethcathinone.

44. Fluoromethcathinone.

45. Methylethcathinone.

46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol) and its dimethyloctyl (C8) homologue.

47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].

48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).

49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).

50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole).

51. BZP (Benzylpiperazine).

52. Fluorophenylpiperazine.

53. Methylphenylpiperazine.

54. Chlorophenylpiperazine.

55. Methoxyphenylpiperazine.

56. DBZP (1,4-Dibenzylpiperazine).

57. TFMPP (Trifluoromethylphenylpiperazine).

58. MBDB (Methylbenzodioxolylbutanamine) or (3,4-Methylenedioxy-N-methylbutanamine).

59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).

60. 5-Hydroxy-N-methyltryptamine.

61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).

62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).

63. Methyltryptamine.

64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).

65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).

66. Tyramine (4-Hydroxyphenethylamine).

67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).

68. DiPT (N,N-Diisopropyltryptamine).

69. DPT (N,N-Dipropyltryptamine).

70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).

71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).

72. DOI (4-Iodo-2,5-dimethoxyamphetamine).

73. DOC (4-Chloro-2,5-dimethoxyamphetamine).

74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).

75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).

76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).

77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).

78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).

79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).

80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).

81. Butylone (3,4-Methylenedioxy-alpha-methylaminobutyrophenone).

82. Ethcathinone.

83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).

84. Naphyrone (Naphthylpyrovalerone).

85. Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).

86. 3,4-Methylenedioxy-N,N-diethylcathinone.

87. 3,4-Methylenedioxy-propiophenone.

88. 3,4-Methylenedioxy-alpha-bromopropiophenone.

89. 3,4-Methylenedioxy-propiophenone-2-oxime.

90. 3,4-Methylenedioxy-N-acetylcathinone.

91. 3,4-Methylenedioxy-N-acetylmethcathinone.

92. 3,4-Methylenedioxy-N-acetylethcathinone.

93. Bromomethcathinone.

94. Buphedrone (alpha-Methylamino-butyrophenone).

95. Eutylone (3,4-Methylenedioxy-alpha-ethylaminobutyrophenone).

96. Dimethylcathinone.

97. Dimethylmethcathinone.

98. Pentylone (3,4-Methylenedioxy-alpha-methylaminovalerophenone).

99. MDPPP (3,4-Methylenedioxy-alpha-pyrrolidinopropiophenone).

100. MDPBP (3,4-Methylenedioxy-alpha-pyrrolidinobutyrophenone).

101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).

102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).

103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP (Benocyclidine).

104. F-MABP (Fluoromethylaminobutyrophenone).

105. MeO-PBP (Methoxypyrrolidinobutyrophenone).

106. Et-PBP (Ethylpyrrolidinobutyrophenone).

107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).

108. Me-EABP (Methylethylaminobutyrophenone).

109. Etizolam.

110. PPP (Pyrrolidinopropiophenone).

111. PBP (Pyrrolidinobutyrophenone).

112. PVP (Pyrrolidinovalerophenone) or (Pyrrolidinopentiophenone).

113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).

114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).

115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).

116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).

117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).

118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).

119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).

120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).

121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).

123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).

124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).

125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).

126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).

127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).

128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).

129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).

130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).

131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).

132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione).

133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).

134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecanamide).

135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecanamide).

136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2-methyloctan-2-yl)phenol).

137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).

138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).

139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).

140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole).

141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone).

142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone).

143. Pentedrone (alpha-Methylaminovalerophenone).

144. Fluoroamphetamine.

145. Fluoromethamphetamine.

146. Methoxetamine.

147. Methiopropamine.

148. Methylbuphedrone (Methyl-alpha-methylaminobutyrophenone).

149. APB ((2-Aminopropyl)benzofuran).

150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).

151. UR-144 (1-Pentyl-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).

155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-iodobenzoyl)indole).

156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-carboxamide).

157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)-cyclohexylcarbamate).

158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid, cyclohexyl ester).

159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one).

160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).

161. 2C-H (2,5-Dimethoxyphenethylamine).

162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).

163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).

164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).

165. MDMA (3,4-Methylenedioxymethamphetamine).

166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).

167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-carboxylate).

168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3-carboxylate).

169. Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole-3-carboxamide).

170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide).

171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).

172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide).

173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(fluoropentyl)indole-3-carboxamide).

174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).

175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).

176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-carboxylate).

178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole-3-carboxamide).

179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).

180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).

181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl-1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).

182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol).

183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol).

184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9 diol).

185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-1-ol).

186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).

187. MAPB ((2-Methylaminopropyl)benzofuran).

188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).

189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).

190. Synthetic Cannabinoids.—Unless specifically excepted or unless listed in another schedule or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation that contains any quantity of a synthetic cannabinoid found to be in any of the following chemical class descriptions, or homologues, nitrogen-heterocyclic analogs, isomers (including optical, positional, or geometric), esters, ethers, salts, and salts of homologues, nitrogen-heterocyclic analogs, isomers, esters, or ethers, whenever the existence of such homologues, nitrogen-heterocyclic analogs, isomers, esters, ethers, salts, and salts of isomers, esters, or ethers is possible within the specific chemical class or designation. Since nomenclature of these synthetically produced cannabinoids is not internationally standardized and may continually evolve, these structures or the compounds of these structures shall be included under this subparagraph, regardless of their specific numerical designation of atomic positions covered, if it can be determined through a recognized method of scientific testing or analysis that the substance contains properties that fit within one or more of the following categories:

a. Tetrahydrocannabinols.—Any tetrahydrocannabinols naturally contained in a plant of the genus Cannabis, the synthetic equivalents of the substances contained in the plant or in the resinous extracts of the genus Cannabis, or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity, including, but not limited to, Delta 9 tetrahydrocannabinols and their optical isomers, Delta 8 tetrahydrocannabinols and their optical isomers, Delta 6a,10a tetrahydrocannabinols and their optical isomers, or any compound containing a tetrahydrobenzo[c]chromene structure with substitution at either or both the 3-position or 9-position, with or without substitution at the 1-position with hydroxyl or alkoxy groups, including, but not limited to:

(I) Tetrahydrocannabinol.

(II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).

(III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).

(IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

(V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

(VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

(VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3-dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).

(VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).

(IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).

(X) Parahexyl.

b. Naphthoylindoles, Naphthoylindazoles, Naphthoylcarbazoles, Naphthylmethylindoles, Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any compound containing a naphthoylindole, naphthoylindazole, naphthoylcarbazole, naphthylmethylindole, naphthylmethylindazole, or naphthylmethylcarbazole structure, with or without substitution on the indole, indazole, or carbazole ring to any extent, whether or not substituted on the naphthyl ring to any extent, including, but not limited to:

(I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).

(II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1-naphthoyl)indole).

(III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).

(IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).

(V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).

(VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).

(VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).

(VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).

(IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).

(X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).

(XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).

(XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).

(XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).

(XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole).

(XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).

(XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).

(XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1-naphthoyl)indole).

(XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).

(XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).

(XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).

(XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).

(XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1-naphthylmethyl]indole).

(XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1-naphthoyl)indole).

(XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1-naphthoyl)indole).

(XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole).

(XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).

(XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).

(XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).

(XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).

(XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).

(XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1-naphthoyl)indole).

(XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1-naphthoyl)indole).

(XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).

(XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1-naphthoyl)indole).

(XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1-naphthoyl)indole).

(XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).

(XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).

(XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1-naphthoyl)indole).

(XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole).

(XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).

(XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1-naphthoyl)carbazole).

c. Naphthoylpyrroles.—Any compound containing a naphthoylpyrrole structure, with or without substitution on the pyrrole ring to any extent, whether or not substituted on the naphthyl ring to any extent, including, but not limited to:

(I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).

(II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).

(III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).

(IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).

(V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).

(VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole).

(VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1-naphthoyl)pyrrole).

(VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1-naphthoyl)pyrrole).

(IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1-naphthoyl)pyrrole).

(X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole).

d. Naphthylmethylenindenes.—Any compound containing a naphthylmethylenindene structure, with or without substitution at the 3-position of the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent, including, but not limited to, JWH-176 (3-Pentyl-1-(naphthylmethylene)indene).

e. Phenylacetylindoles and Phenylacetylindazoles.—Any compound containing a phenylacetylindole or phenylacetylindazole structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the phenyl ring to any extent, including, but not limited to:

(I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).

(II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).

(III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).

(IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).

(V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).

(VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).

(VII) Cannabipiperidiethanone.

(VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole).

f. Cyclohexylphenols.—Any compound containing a cyclohexylphenol structure, with or without substitution at the 5-position of the phenolic ring to any extent, whether or not substituted on the cyclohexyl ring to any extent, including, but not limited to:

(I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol).

(II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8) homologue).

(III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2-methyloctan-2-yl)phenol).

g. Benzoylindoles and Benzoylindazoles.—Any compound containing a benzoylindole or benzoylindazole structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the phenyl ring to any extent, including, but not limited to:

(I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).

(II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).

(III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-iodo-5-nitrobenzoyl)indole).

(IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4-methoxybenzoyl)indole).

(V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-iodobenzoyl)indole).

(VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).

(VII) RCS-4 C4 homologue (1-Butyl-3-(4-methoxybenzoyl)indole).

(VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo-3-(4-methoxybenzoyl)indole).

h. Tetramethylcyclopropanoylindoles and Tetramethylcyclopropanoylindazoles.—Any compound containing a tetramethylcyclopropanoylindole or tetramethylcyclopropanoylindazole structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the tetramethylcyclopropyl group to any extent, including, but not limited to:

(I) UR-144 (1-Pentyl-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

(II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

(III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

(IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

(V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

(VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

(VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

(VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropanoyl)indazole).

(IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

(X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).

i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole carboxamides, and Adamantylindazole carboxamides.—Any compound containing an adamantoyl indole, adamantoyl indazole, adamantyl indole carboxamide, or adamantyl indazole carboxamide structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the adamantyl ring to any extent, including, but not limited to:

(I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).

(II) Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole-3-carboxamide).

(III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-carboxamide).

(IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1-adamantoyl)indole).

(V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).

(VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).

(VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1-adamantoyl)indole).

j. Quinolinylindolecarboxylates, Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides, and Quinolinylindazolecarboxamides.—Any compound containing a quinolinylindole carboxylate, quinolinylindazole carboxylate, isoquinolinylindole carboxylate, isoquinolinylindazole carboxylate, quinolinylindole carboxamide, quinolinylindazole carboxamide, isoquinolinylindole carboxamide, or isoquinolinylindazole carboxamide structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the quinoline or isoquinoline ring to any extent, including, but not limited to:

(I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).

(II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-carboxylate).

(III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3-carboxylate).

(IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-carboxylate).

(V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).

(VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole-3-carboxylate).

(VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole-3-carboxylate).

(VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).

(IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3-carboxamide).

k. Naphthylindolecarboxylates and Naphthylindazolecarboxylates.—Any compound containing a naphthylindole carboxylate or naphthylindazole carboxylate structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the naphthyl ring to any extent, including, but not limited to:

(I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3-carboxylate).

(II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3-carboxylate).

(III) Fluoro SDB-005 (1-Naphthalenyl 1-(fluoropentyl)indazole-3-carboxylate).

(IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3-carboxylate).

(V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3-carboxylate).

l. Naphthylindole carboxamides and Naphthylindazole carboxamides.—Any compound containing a naphthylindole carboxamide or naphthylindazole carboxamide structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the naphthyl ring to any extent, including, but not limited to:

(I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).

(II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole-3-carboxamide).

(III) Chloro-NNEI (N-Naphthalen-1-yl 1-(chloropentyl)indole-3-carboxamide).

(IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3-carboxamide).

(V) Fluoro MN-18 (N-Naphthalen-1-yl 1-(fluoropentyl)indazole-3-carboxamide).

m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl indazole carboxamides, Alkylcarbonyl indole carboxylates, and Alkylcarbonyl indazole carboxylates.—Any compound containing an alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3-phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an indole carboxamide, indazole carboxamide, indole carboxylate, or indazole carboxylate, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the alkylcarbonyl group to any extent, including, but not limited to:

(I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentylindole-3-carboxamide).

(II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(fluoropentyl)indole-3-carboxamide).

(III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(fluoropentyl)indole-3-carboxamide).

(IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide).

(V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).

(VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide).

(VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).

(VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).

(IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).

(X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

(XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

(XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

(XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide).

(XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).

(XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).

(XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

(XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).

(XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).

(XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)indole-3-carboxamide).

(XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)indazole-3-carboxamide).

(XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).

(XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).

(XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).

n. Cumylindolecarboxamides and Cumylindazolecarboxamides.—Any compound containing a N-(2-phenylpropan-2-yl) indole carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide structure, with or without substitution on the indole or indazole ring to any extent, whether or not substituted on the phenyl ring of the cumyl group to any extent, including, but not limited to:

(I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3-carboxamide).

(II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-(fluoropentyl)indole-3-carboxamide).

o. Other Synthetic Cannabinoids.—Any material, compound, mixture, or preparation that contains any quantity of a Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:

(I) With or without modification or replacement of a carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage between either two core rings, or linkage between a core ring and group structure, with or without the addition of a carbon or replacement of a carbon;

(II) With or without replacement of a core ring or group structure, whether or not substituted on the ring or group structures to any extent; and

(III) Is a cannabinoid receptor agonist, unless specifically excepted or unless listed in another schedule or contained within a pharmaceutical product approved by the United States Food and Drug Administration.

191. Substituted Cathinones.—Unless specifically excepted, listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations:

a. Any compound containing a 2-amino-1-phenyl-1-propanone structure;

b. Any compound containing a 2-amino-1-naphthyl-1-propanone structure; or

c. Any compound containing a 2-amino-1-thiophenyl-1-propanone structure,

whether or not the compound is further modified:

(I) With or without substitution on the ring system to any extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy, haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide substituents;

(II) With or without substitution at the 3-propanone position with an alkyl substituent or removal of the methyl group at the 3-propanone position;

(III) With or without substitution at the 2-amino nitrogen atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or not further substituted in the ring system; or

(IV) With or without inclusion of the 2-amino nitrogen atom in a cyclic structure, including, but not limited to:

(A) Methcathinone.

(B) Ethcathinone.

(D) 2,3-Methylenedioxymethcathinone.

(E) MDPV (3,4-Methylenedioxypyrovalerone).

(F) Methylmethcathinone.

(G) Methoxymethcathinone.

(H) Fluoromethcathinone.

(I) Methylethcathinone.

(J) Butylone (3,4-Methylenedioxy-alpha-methylaminobutyrophenone).

(K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).

(L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).

(M) Naphyrone (Naphthylpyrovalerone).

(N) Bromomethcathinone.

(O) Buphedrone (alpha-Methylaminobutyrophenone).

(P) Eutylone (3,4-Methylenedioxy-alpha-ethylaminobutyrophenone).

(Q) Dimethylcathinone.

(R) Dimethylmethcathinone.

(S) Pentylone (3,4-Methylenedioxy-alpha-methylaminovalerophenone).

(T) Pentedrone (alpha-Methylaminovalerophenone).

(U) MDPPP (3,4-Methylenedioxy-alpha-pyrrolidinopropiophenone).

(V) MDPBP (3,4-Methylenedioxy-alpha-pyrrolidinobutyrophenone).

(W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).

(X) PPP (Pyrrolidinopropiophenone).

(Y) PVP (Pyrrolidinovalerophenone) or (Pyrrolidinopentiophenone).

(Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).

(AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).

(BB) F-MABP (Fluoromethylaminobutyrophenone).

(CC) Me-EABP (Methylethylaminobutyrophenone).

(DD) PBP (Pyrrolidinobutyrophenone).

(EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).

(FF) Et-PBP (Ethylpyrrolidinobutyrophenone).

(GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).

(HH) Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).

(II) 3,4-Methylenedioxy-N,N-diethylcathinone.

(JJ) 3,4-Methylenedioxy-N-acetylcathinone.

(KK) 3,4-Methylenedioxy-N-acetylmethcathinone.

(LL) 3,4-Methylenedioxy-N-acetylethcathinone.

(MM) Methylbuphedrone (Methyl-alpha-methylaminobutyrophenone).

(NN) Methyl-alpha-methylaminohexanophenone.

(OO) N-Ethyl-N-methylcathinone.

(PP) PHP (Pyrrolidinohexanophenone).

(QQ) PV8 (Pyrrolidinoheptanophenone).

(RR) Chloromethcathinone.

(SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.

192. Substituted Phenethylamines.—Unless specifically excepted or unless listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations, any compound containing a phenethylamine structure, without a beta-keto group, and without a benzyl group attached to the amine group, whether or not the compound is further modified with or without substitution on the phenyl ring to any extent with alkyl, alkylthio, nitro, alkoxy, thio, halide, fused alkylenedioxy, fused furan, fused benzofuran, fused dihydrofuran, or fused tetrahydropyran substituents, whether or not further substituted on a ring to any extent, with or without substitution at the alpha or beta position by any alkyl substituent, with or without substitution at the nitrogen atom, and with or without inclusion of the 2-amino nitrogen atom in a cyclic structure, including, but not limited to:

a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).

b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).

c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).

d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).

e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).

f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).

g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).

h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).

i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).

j. 2C-H (2,5-Dimethoxyphenethylamine).

k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).

l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).

m. MDMA (3,4-Methylenedioxymethamphetamine).

n. MBDB (Methylbenzodioxolylbutanamine) or (3,4-Methylenedioxy-N-methylbutanamine).

o. MDA (3,4-Methylenedioxyamphetamine).

p. 2,5-Dimethoxyamphetamine.

q. Fluoroamphetamine.

r. Fluoromethamphetamine.

s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).

t. DOB (4-Bromo-2,5-dimethoxyamphetamine).

u. DOC (4-Chloro-2,5-dimethoxyamphetamine).

v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).

w. DOI (4-Iodo-2,5-dimethoxyamphetamine).

x. DOM (4-Methyl-2,5-dimethoxyamphetamine).

y. PMA (4-Methoxyamphetamine).

z. N-Ethylamphetamine.

aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.

bb. 5-Methoxy-3,4-methylenedioxyamphetamine.

cc. PMMA (4-Methoxymethamphetamine).

dd. N,N-Dimethylamphetamine.

ee. 3,4,5-Trimethoxyamphetamine.

ff. 4-APB (4-(2-Aminopropyl)benzofuran).

gg. 5-APB (5-(2-Aminopropyl)benzofuran).

hh. 6-APB (6-(2-Aminopropyl)benzofuran).

ii. 7-APB (7-(2-Aminopropyl)benzofuran).

jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).

kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).

ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).

mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).

nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).

oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).

pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).

qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).

rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).

ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3-dihydrobenzofuran),

which does not include phenethylamine, mescaline as described in subparagraph 20., substituted cathinones as described in subparagraph 191., N-Benzyl phenethylamine compounds as described in subparagraph 193., or methamphetamine as described in subparagraph (2)(c)5.

193. N-Benzyl Phenethylamine Compounds.—Unless specifically excepted or unless listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations, any compound containing a phenethylamine structure without a beta-keto group, with substitution on the nitrogen atom of the amino group with a benzyl substituent, with or without substitution on the phenyl or benzyl ring to any extent with alkyl, alkoxy, thio, alkylthio, halide, fused alkylenedioxy, fused furan, fused benzofuran, or fused tetrahydropyran substituents, whether or not further substituted on a ring to any extent, with or without substitution at the alpha position by any alkyl substituent, including, but not limited to:

a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).

b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2-hydroxybenzyl)]phenethylamine).

c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2-fluorobenzyl)]phenethylamine).

d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3-methylenedioxybenzyl)]phenethylamine).

e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).

f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2-hydroxybenzyl)]phenethylamine).

g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2-fluorobenzyl)]phenethylamine).

h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3-methylenedioxybenzyl)]phenethylamine).

i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).

j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).

k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).

l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).

m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2-hydroxybenzyl)]phenethylamine).

n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2-fluorobenzyl)]phenethylamine).

o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3-methylenedioxybenzyl)]phenethylamine).

p. 25H-NBOMe (2,5-Dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).

q. 25H-NBOH (2,5-Dimethoxy-[N-(2-hydroxybenzyl)]phenethylamine).

r. 25H-NBF (2,5-Dimethoxy-[N-(2-fluorobenzyl)]phenethylamine).

s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine),

which does not include substituted cathinones as described in subparagraph 191.

194. Substituted Tryptamines.—Unless specifically excepted or unless listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation containing a 2-(1H-indol-3-yl)ethanamine, for example tryptamine, structure with or without mono- or di-substitution of the amine nitrogen with alkyl or alkenyl groups, or by inclusion of the amino nitrogen atom in a cyclic structure, whether or not substituted at the alpha position with an alkyl group, whether or not substituted on the indole ring to any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy groups, including, but not limited to:

a. Alpha-Ethyltryptamine.

b. Bufotenine.

c. DET (Diethyltryptamine).

d. DMT (Dimethyltryptamine).

e. MET (N-Methyl-N-ethyltryptamine).

f. DALT (N,N-Diallyltryptamine).

g. EiPT (N-Ethyl-N-isopropyltryptamine).

h. MiPT (N-Methyl-N-isopropyltryptamine).

i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).

j. 5-Hydroxy-N-methyltryptamine.

k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).

l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).

m. Methyltryptamine.

n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).

o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).

p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).

q. DiPT (N,N-Diisopropyltryptamine).

r. DPT (N,N-Dipropyltryptamine).

s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).

t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).

u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).

v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).

w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).

x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).

y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N-isopropyltryptamine).

z. Methyl-alpha-ethyltryptamine.

aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),

which does not include tryptamine, psilocyn as described in subparagraph 34., or psilocybin as described in subparagraph 33.

195. Substituted Phenylcyclohexylamines.—Unless specifically excepted or unless listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any material, compound, mixture, or preparation containing a phenylcyclohexylamine structure, with or without any substitution on the phenyl ring, any substitution on the cyclohexyl ring, any replacement of the phenyl ring with a thiophenyl or benzothiophenyl ring, with or without substitution on the amine with alkyl, dialkyl, or alkoxy substituents, inclusion of the nitrogen in a cyclic structure, or any combination of the above, including, but not limited to:

a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP (Benocyclidine).

b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog of phencyclidine).

c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine analog of phencyclidine).

d. PCPr (Phenylcyclohexylpropylamine).

e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene analog of phencyclidine).

f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).

g. PCMPA (Phenylcyclohexyl(methoxypropylamine)).

h. Methoxetamine.

i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).

j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).

k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).

l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).

m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).

n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).

o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).

p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).

q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).

r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).

196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2-piperidinylidene]-benzenesulfonamide.

197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide.

198. AH-7921, 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]-benzamide.

199. U47700, trans-3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methyl-benzamide.

200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine, dihydrochloride.

(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances, including any of its salts, isomers, optical isomers, salts of their isomers, and salts of these optical isomers whenever the existence of such isomers and salts is possible within the specific chemical designation:

1. 1,4-Butanediol.

2. Gamma-butyrolactone (GBL).

3. Gamma-hydroxybutyric acid (GHB).

4. Methaqualone.

5. Mecloqualone.

(2) SCHEDULE II.—A substance in Schedule II has a high potential for abuse and has a currently accepted but severely restricted medical use in treatment in the United States, and abuse of the substance may lead to severe psychological or physical dependence. The following substances are controlled in Schedule II:

(a) Unless specifically excepted or unless listed in another schedule, any of the following substances, whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis:

1. Opium and any salt, compound, derivative, or preparation of opium, except nalmefene or isoquinoline alkaloids of opium, including, but not limited to the following:

a. Raw opium.

b. Opium extracts.

c. Opium fluid extracts.

d. Powdered opium.

e. Granulated opium.

f. Tincture of opium.

g. Codeine.

h. Dihydroetorphine.

i. Ethylmorphine.

j. Etorphine hydrochloride.

k. Hydrocodone and hydrocodone combination products.

l. Hydromorphone.

m. Levo-alphacetylmethadol (also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM).

n. Metopon (methyldihydromorphinone).

o. Morphine.

p. Oripavine.

q. Oxycodone.

r. Oxymorphone.

s. Thebaine.

2. Any salt, compound, derivative, or preparation of a substance which is chemically equivalent to or identical with any of the substances referred to in subparagraph 1., except that these substances shall not include the isoquinoline alkaloids of opium.

3. Any part of the plant of the species Papaver somniferum, L.

4. Cocaine or ecgonine, including any of their stereoisomers, and any salt, compound, derivative, or preparation of cocaine or ecgonine, except that these substances shall not include ioflupane I 123.

(b) Unless specifically excepted or unless listed in another schedule, any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

1. Alfentanil.

2. Alphaprodine.

3. Anileridine.

4. Bezitramide.

5. Bulk propoxyphene (nondosage forms).

6. Carfentanil.

7. Dihydrocodeine.

8. Diphenoxylate.

9. Fentanyl.

10. Isomethadone.

11. Levomethorphan.

12. Levorphanol.

13. Metazocine.

14. Methadone.

15. Methadone-Intermediate,4-cyano-2-
dimethylamino-4,4-diphenylbutane.

16. Moramide-Intermediate,2-methyl-
3-morpholoino-1,1-diphenylpropane-carboxylic acid.

17. Nabilone.

18. Pethidine (meperidine).

19. Pethidine-Intermediate-A,4-cyano-1-
methyl-4-phenylpiperidine.

20. Pethidine-Intermediate-B,ethyl-4-
phenylpiperidine-4-carboxylate.

21. Pethidine-Intermediate-C,1-methyl-4- phenylpiperidine-4-carboxylic acid.

22. Phenazocine.

23. Phencyclidine.

24. 1-Phenylcyclohexylamine.

25. Piminodine.

26. 1-Piperidinocyclohexanecarbonitrile.

27. Racemethorphan.

28. Racemorphan.

29. Remifentanil.

30. Sufentanil.

31. Tapentadol.

32. Thiafentanil.

(c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including their salts, isomers, optical isomers, salts of their isomers, and salts of their optical isomers:

1. Amobarbital.

2. Amphetamine.

3. Glutethimide.

4. Lisdexamfetamine.

5. Methamphetamine.

6. Methylphenidate.

7. Pentobarbital.

8. Phenmetrazine.

9. Phenylacetone.

10. Secobarbital.

(d) Dronabinol (synthetic THC) in oral solution in a drug product approved by the United States Food and Drug Administration.

(3) SCHEDULE III.—A substance in Schedule III has a potential for abuse less than the substances contained in Schedules I and II and has a currently accepted medical use in treatment in the United States, and abuse of the substance may lead to moderate or low physical dependence or high psychological dependence or, in the case of anabolic steroids, may lead to physical damage. The following substances are controlled in Schedule III:

(a) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant or stimulant effect on the nervous system:

1. Any substance which contains any quantity of a derivative of barbituric acid, including thiobarbituric acid, or any salt of a derivative of barbituric acid or thiobarbituric acid, including, but not limited to, butabarbital and butalbital.

2. Benzphetamine.

3. Buprenorphine.

4. Chlorhexadol.

5. Chlorphentermine.

6. Clortermine.

7. Embutramide.

8. Lysergic acid.

9. Lysergic acid amide.

10. Methyprylon.

11. Perampanel.

12. Phendimetrazine.

13. Sulfondiethylmethane.

14. Sulfonethylmethane.

15. Sulfonmethane.

16. Tiletamine and zolazepam or any salt thereof.

(b) Nalorphine.

(c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following controlled substances or any salts thereof:

1. Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.

2. Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with recognized therapeutic amounts of one or more active ingredients which are not controlled substances.

3. Not more than 300 milligrams of hydrocodone per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.

4. Not more than 300 milligrams of hydrocodone per 100 milliliters or not more than 15 milligrams per dosage unit, with recognized therapeutic amounts of one or more active ingredients that are not controlled substances.

5. Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with recognized therapeutic amounts of one or more active ingredients which are not controlled substances.

6. Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

7. Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with recognized therapeutic amounts of one or more active ingredients which are not controlled substances.

For purposes of charging a person with a violation of s. 893.135 involving any controlled substance described in subparagraph 3. or subparagraph 4., the controlled substance is a Schedule III controlled substance pursuant to this paragraph but the weight of the controlled substance per milliliters or per dosage unit is not relevant to the charging of a violation of s. 893.135. The weight of the controlled substance shall be determined pursuant to s. 893.135(6).

(d) Anabolic steroids.

1. The term “anabolic steroid” means any drug or hormonal substance, chemically and pharmacologically related to testosterone, other than estrogens, progestins, and corticosteroids, that promotes muscle growth and includes:

a. Androsterone.

b. Androsterone acetate.

c. Boldenone.

d. Boldenone acetate.

e. Boldenone benzoate.

f. Boldenone undecylenate.

g. Chlorotestosterone (Clostebol).

h. Dehydrochlormethyltestosterone.

i. Dihydrotestosterone (Stanolone).

j. Drostanolone.

k. Ethylestrenol.

l. Fluoxymesterone.

m. Formebulone (Formebolone).

n. Mesterolone.

o. Methandrostenolone (Methandienone).

p. Methandranone.

q. Methandriol.

r. Methenolone.

s. Methyltestosterone.

t. Mibolerone.

u. Nortestosterone (Nandrolone).

v. Norethandrolone.

w. Nortestosterone decanoate.

x. Nortestosterone phenylpropionate.

y. Nortestosterone propionate.

z. Oxandrolone.

aa. Oxymesterone.

bb. Oxymetholone.

cc. Stanozolol.

dd. Testolactone.

ee. Testosterone.

ff. Testosterone acetate.

gg. Testosterone benzoate.

hh. Testosterone cypionate.

ii. Testosterone decanoate.

jj. Testosterone enanthate.

kk. Testosterone isocaproate.

ll. Testosterone oleate.

mm. Testosterone phenylpropionate.

nn. Testosterone propionate.

oo. Testosterone undecanoate.

pp. Trenbolone.

qq. Trenbolone acetate.

rr. Any salt, ester, or isomer of a drug or substance described or listed in this subparagraph if that salt, ester, or isomer promotes muscle growth.

2. The term does not include an anabolic steroid that is expressly intended for administration through implants to cattle or other nonhuman species and that has been approved by the United States Secretary of Health and Human Services for such administration. However, any person who prescribes, dispenses, or distributes such a steroid for human use is considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this paragraph.

(e) Ketamine, including any isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation.

(f) Dronabinol (synthetic THC) in sesame oil and encapsulated in a soft gelatin capsule in a drug product approved by the United States Food and Drug Administration.

(g) Any drug product containing gamma-hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under s. 505 of the Federal Food, Drug, and Cosmetic Act.

(4) SCHEDULE IV.—

(a) A substance in Schedule IV has a low potential for abuse relative to the substances in Schedule III and has a currently accepted medical use in treatment in the United States, and abuse of the substance may lead to limited physical or psychological dependence relative to the substances in Schedule III.

(b) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, are controlled in Schedule IV:

1. Alfaxalone.

2. Alprazolam.

3. Barbital.

4. Bromazepam.

5. Butorphanol tartrate.

6. Camazepam.

7. Carisoprodol.

8. Cathine.

9. Chloral betaine.

10. Chloral hydrate.

11. Chlordiazepoxide.

12. Clobazam.

13. Clonazepam.

14. Clorazepate.

15. Clotiazepam.

16. Cloxazolam.

17. Dexfenfluramine.

18. Delorazepam.

19. Dichloralphenazone.

20. Diazepam.

21. Diethylpropion.

22. Eluxadoline.

23. Estazolam.

24. Eszopiclone.

25. Ethchlorvynol.

26. Ethinamate.

27. Ethyl loflazepate.

28. Fencamfamin.

¹29. Fenfluramine.

30. Fenproporex.

31. Fludiazepam.

32. Flurazepam.

33. Fospropofol.

34. Halazepam.

35. Haloxazolam.

36. Ketazolam.

37. Loprazolam.

38. Lorazepam.

39. Lorcaserin.

40. Lormetazepam.

41. Mazindol.

42. Mebutamate.

43. Medazepam.

44. Mefenorex.

45. Meprobamate.

46. Methohexital.

47. Methylphenobarbital.

48. Midazolam.

49. Modafinil.

50. Nimetazepam.

51. Nitrazepam.

52. Nordiazepam.

53. Oxazepam.

54. Oxazolam.

55. Paraldehyde.

56. Pemoline.

57. Pentazocine.

58. Petrichloral.

59. Phenobarbital.

60. Phentermine.

61. Pinazepam.

62. Pipradrol.

63. Prazepam.

64. Propoxyphene (dosage forms).

65. Propylhexedrine, excluding any patent or proprietary preparation containing propylhexedrine, unless otherwise provided by federal law.

66. Quazepam.

67. Sibutramine.

68. SPA[(-)-1 dimethylamino-1, 2
diphenylethane].

69. Suvorexant.

70. Temazepam.

71. Tetrazepam.

72. Tramadol.

73. Triazolam.

74. Zaleplon.

75. Zolpidem.

76. Zopiclone.

77. Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.

(5) SCHEDULE V.—A substance, compound, mixture, or preparation of a substance in Schedule V has a low potential for abuse relative to the substances in Schedule IV and has a currently accepted medical use in treatment in the United States, and abuse of such compound, mixture, or preparation may lead to limited physical or psychological dependence relative to the substances in Schedule IV.

(a) Substances controlled in Schedule V include any compound, mixture, or preparation containing any of the following limited quantities of controlled substances, which must include one or more active medicinal ingredients that are not controlled substances in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the controlled substance alone:

1. Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.

2. Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams.

3. Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams.

4. Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.

5. Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.

6. Not more than 0.5 milligrams of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.

(b) Unless a specific exception exists or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances is controlled in Schedule V:

1. Brivaracetam.

2. Ezogabine.

3. Lacosamide.

4. Pregabalin.

(c) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers: Pyrovalerone.

History.—s. 3, ch. 73-331; s. 247, ch. 77-104; s. 1, ch. 77-174; ss. 1, 2, ch. 78-195; s. 2, ch. 79-325; s. 1, ch. 80-353; s. 1, ch. 82-16; s. 1, ch. 84-89; s. 2, ch. 85-242; s. 1, ch. 86-147; s. 2, ch. 87-243; s. 1, ch. 87-299; s. 1, ch. 88-59; s. 3, ch. 89-281; s. 54, ch. 92-69; s. 1, ch. 93-92; s. 4, ch. 95-415; s. 1, ch. 96-360; ss. 1, 5, ch. 97-1; s. 96, ch. 97-264; s. 1, ch. 99-186; s. 2, ch. 2000-320; s. 1, ch. 2001-55; s. 5, ch. 2001-57; s. 1, ch. 2002-78; s. 2, ch. 2003-10; s. 1, ch. 2008-88; s. 2, ch. 2011-73; s. 1, ch. 2011-90; s. 1, ch. 2012-23; s. 1, ch. 2013-29; s. 1, ch. 2014-159; s. 1, ch. 2015-34; s. 2, ch. 2016-105; s. 4, ch. 2017-107; s. 1, ch. 2017-110; s. 8, ch. 2018-13; s. 2, ch. 2019-166; s. 1, ch. 2021-154; s. 1, ch. 2023-221; s. 1, ch. 2024-20.

¹Note.—Section 5, ch. 97-1, repealed paragraph (4)(w) effective upon the removal of fenfluramine from the schedules of controlled substances in 21 C.F.R. s. 1308. Paragraph (4)(w) was redesignated as subparagraph (4)(b)29. by s. 8, ch. 2018-3. The Drug Enforcement Administration, United States Department of Justice, in FR Doc. 2022-27400, filed December 22, 2022, issued a final rule removing fenfluramine from the schedules of the Controlled Substances Act, effective December 23, 2022.

F.S. 893.03 on Google Scholar

F.S. 893.03 on CourtListener

Amendments to 893.03

Annotations, Discussions, Cases:

Cases Citing Statute 893.03

Total Results: 226

United States v. Steven Gibson

434 F.3d 1234, 2006 U.S. App. LEXIS 60, 2006 WL 12894

Court of Appeals for the Eleventh Circuit | Filed: Jan 4, 2006 | Docket: 913058

Cited 146 times | Published

is such a controlled substance. Fla. Stat. Ann. § 893.03(2)(a)(4) (West 2005). Florida classifies this

Hayes v. State

750 So. 2d 1, 1999 WL 817189

Supreme Court of Florida | Filed: Oct 7, 1999 | Docket: 1736668

Cited 134 times | Published

thereof, including heroin, as described in section 893.03(1)(b) [Schedule I] or (2)(a) [Schedule II]

State v. Weller

590 So. 2d 923, 1991 WL 231597

Supreme Court of Florida | Filed: Nov 7, 1991 | Docket: 458247

Cited 84 times | Published

contrary to F.S. 893.135(4), F.S. 893.135(1)(b)(3), F.S. 893.03(2)(a)(4) and F.S. 893.13(1)(a)(1). The law requires

United States v. Alphonso James, Jr.

430 F.3d 1150, 2005 U.S. App. LEXIS 24665, 2005 WL 3070485

Court of Appeals for the Eleventh Circuit | Filed: Nov 17, 2005 | Docket: 2040397

Cited 65 times | Published

28 grams or more of cocaine, as described in § 893.03(2)(a)4., or of any mixture containing cocaine

United States v. Larry Frazier, United States of America v. Darence Eugene Hutchinson, Kenya Brown, Albert Lintez Brown, A/K/A "Pee Pee" A/K/A "James", Henry Graham, Raymond D. Griffin, Kenyatta Brown

89 F.3d 1501, 1996 U.S. App. LEXIS 19010

Court of Appeals for the Eleventh Circuit | Filed: Aug 2, 1996 | Docket: 1012332

Cited 58 times | Published

3 Florida Statutes § 893.03 sets forth the state's standards and schedules

Hively v. State

336 So. 2d 127

District Court of Appeal of Florida | Filed: Jul 16, 1976 | Docket: 1378577

Cited 45 times | Published

controlled substance. Section 893.02(3) and Section 893.03(1)(c), Florida Statutes 1973. For the purposes

State v. Burch

545 So. 2d 279, 1989 WL 9141

District Court of Appeal of Florida | Filed: Feb 8, 1989 | Docket: 1702744

Cited 33 times | Published

controlled substance named or described in section 893.03(1)(a), (1)(b)(1)(d), (2)(a), or (2)(b) is guilty

United States v. Shannon

631 F.3d 1187, 2011 WL 227677

Court of Appeals for the Eleventh Circuit | Filed: Jan 26, 2011 | Docket: 1870027

Cited 32 times | Published

Cocaine, a controlled substance defined in Section 893.03, contrary to Section 893.135.”3 DE 37-5. The

Shapiro v. State

390 So. 2d 344

Supreme Court of Florida | Filed: Nov 13, 1980 | Docket: 1750355

Cited 32 times | Published

Accordingly, we hold that section 893.13 and section 893.03(2)(a)(4) are constitutional. We further hold

Cilento v. State

377 So. 2d 663

Supreme Court of Florida | Filed: Nov 21, 1979 | Docket: 1521726

Cited 20 times | Published

controlled substance, to wit: methaqualone... ." Section 893.03(3)(a)(6) classifies methaqualone as a Schedule

J.E. v. Department of Children & Families

126 So. 3d 424, 2013 WL 5989154, 2013 Fla. App. LEXIS 18021

District Court of Appeal of Florida | Filed: Nov 13, 2013 | Docket: 60236442

Cited 19 times | Published

constructive possession of a controlled substance ....”); § 893.03(l)(c)(7), Fla. Stat. (2013) (listing "Cannabis”

Willis v. State

320 So. 2d 823

District Court of Appeal of Florida | Filed: Oct 24, 1975 | Docket: 1409130

Cited 18 times | Published

controlled substance. Section 893.02(3) and Section 893.03(4), Florida Statutes 1973. For the purposes

Cohn v. Dept. of Professional Regulation

477 So. 2d 1039, 10 Fla. L. Weekly 2390, 1985 Fla. App. LEXIS 16422

District Court of Appeal of Florida | Filed: Oct 22, 1985 | Docket: 1693677

Cited 15 times | Published

rejected the claim that a criminal statute, section 893.03(2)(c)(1), which forbids the delivering of a

Lee v. State

856 So. 2d 1133, 2003 WL 22399604

District Court of Appeal of Florida | Filed: Oct 22, 2003 | Docket: 1298193

Cited 14 times | Published

with trafficking in cocaine, in violation of section 893.03(2)(a)4., Florida Statutes. Lee moved to suppress

State v. Leicht

402 So. 2d 1153

Supreme Court of Florida | Filed: Jun 25, 1981 | Docket: 1691474

Cited 14 times | Published

of the controlled substances proscribed in section 893.03, Florida Statutes (1979). They claim that many

State v. Ashcraft

378 So. 2d 284

Supreme Court of Florida | Filed: Dec 20, 1979 | Docket: 1795482

Cited 14 times | Published

is a controlled substance under Florida law, section 893.03(2)(c)3, Florida Statutes (1977), and no question

City of St. Petersburg v. Austrino

898 So. 2d 955, 2005 WL 291948

District Court of Appeal of Florida | Filed: Feb 9, 2005 | Docket: 306762

Cited 13 times | Published

1, 1 (Fla.1999). Hydrocodone is governed by section 893.03(3). While a pharmacist can dispense such substances

State v. Estevez

753 So. 2d 1, 1999 WL 1072903

Supreme Court of Florida | Filed: Nov 24, 1999 | Docket: 1433762

Cited 13 times | Published

28 grams or more of cocaine, as described in § 893.03(2)(a)(4)., or of any mixture containing cocaine

State v. Baxley

684 So. 2d 831, 1996 WL 648285

District Court of Appeal of Florida | Filed: Nov 8, 1996 | Docket: 1740926

Cited 13 times | Published

which are not controlled substances, then under section 893.03(3)(c)4 such tablet is a SCHEDULE III substance

GEG v. State

417 So. 2d 975

Supreme Court of Florida | Filed: Jul 15, 1982 | Docket: 1383986

Cited 13 times | Published

whether an object is a controlled substance under section 893.03, Florida Statutes (1981). It is the testimony

Town v. State Ex Rel. Reno

377 So. 2d 648

Supreme Court of Florida | Filed: Nov 1, 1979 | Docket: 1521651

Cited 13 times | Published

classification of cannabis as a Schedule I drug under section 893.03, Florida Statutes (1978 Supp.), irrational

State v. Klayman

835 So. 2d 248, 2002 WL 31519926

Supreme Court of Florida | Filed: Nov 14, 2002 | Docket: 1643097

Cited 10 times | Published

trafficking statute, regardless of the dosage unit. See § 893.03(3), Fla. Stat. (2000). In 2001, the Legislature

State v. Holland

689 So. 2d 1268, 1997 WL 122655

District Court of Appeal of Florida | Filed: Mar 20, 1997 | Docket: 1739379

Cited 10 times | Published

Vicodin, a controlled substance defined in Section 893.03 Florida Statutes, in violation of 893.135 Florida

State v. Vinson

298 So. 2d 505

District Court of Appeal of Florida | Filed: Jul 19, 1974 | Docket: 1438957

Cited 10 times | Published

controlled substance named or described in Section 893.03(2)(c), to-wit: Dexadrine, to TONY HORVATH,

Greenwade v. State

124 So. 3d 215, 38 Fla. L. Weekly Supp. 717, 2013 WL 5641794, 2013 Fla. LEXIS 2284

Supreme Court of Florida | Filed: Oct 17, 2013 | Docket: 60235423

Cited 9 times | Published

controlled substance named or described in [section] 893.03 which, or the container or labeling of which

Carle v. State

983 So. 2d 693, 2008 WL 2276285

District Court of Appeal of Florida | Filed: Jun 5, 2008 | Docket: 1687143

Cited 9 times | Published

is a schedule IV controlled substance under section 893.03(4)(p). Thus, the charged crime was a third-degree

Godfrey v. State

947 So. 2d 565, 2006 WL 3796177

District Court of Appeal of Florida | Filed: Dec 28, 2006 | Docket: 1376901

Cited 9 times | Published

compartment of the defendant's vehicle). Further, section 893.03(2)(a)(4), Florida Statutes (2005), defines

Jenks v. State

582 So. 2d 676, 1991 WL 105517

District Court of Appeal of Florida | Filed: Jun 13, 1991 | Docket: 1715916

Cited 9 times | Published

common law, the state nevertheless contends that Section 893.03, Florida Statutes (1989), is inconsistent with

Menendez v. State

521 So. 2d 210, 1988 WL 13251

District Court of Appeal of Florida | Filed: Feb 16, 1988 | Docket: 1703597

Cited 9 times | Published

of, 28 grams or more of cocaine as described in § 893.03(2)(a)4 or of any mixture containing cocaine is

State v. Weitz

500 So. 2d 657, 12 Fla. L. Weekly 104

District Court of Appeal of Florida | Filed: Dec 30, 1986 | Docket: 1689616

Cited 9 times | Published

DCA 1979). [3] Controlled substances under section 893.03, Florida Statutes (1985). [4] Section 316

Jackson v. State

803 So. 2d 842, 2001 WL 1661470

District Court of Appeal of Florida | Filed: Dec 31, 2001 | Docket: 1785436

Cited 8 times | Published

are second-degree felonies. § 893.13(1)(a)1 & § 893.03(2)(a)4, Fla. Stat. (1991). In March 1991, after

Lang v. State

671 So. 2d 292, 1996 WL 168917

District Court of Appeal of Florida | Filed: Apr 12, 1996 | Docket: 161501

Cited 8 times | Published

PETERSON, C.J., and THOMPSON, J., concur. NOTES [1] § 893.03, Fla.Stat. (1993). [2] § 893.145, Fla.Stat. (1993)

Thomas v. State

633 So. 2d 1122, 1994 WL 63291

District Court of Appeal of Florida | Filed: Mar 4, 1994 | Docket: 1296711

Cited 8 times | Published

III of sale of cocaine, a second degree felony, § 893.03(2)(a)4, Florida Statutes, punishable by up to

Fiske v. State

366 So. 2d 423

Supreme Court of Florida | Filed: Dec 21, 1978 | Docket: 1227301

Cited 8 times | Published

Florida Constitutions. We hold that it does. Section 893.03, Florida Statutes (1975), gives the standards

State v. Weeks

335 So. 2d 274

Supreme Court of Florida | Filed: Jul 8, 1976 | Docket: 1711331

Cited 8 times | Published

controlled substance named or described in section F.S. 893.03(2)(c)(1) [or (2)] ... by use of a written order

Foster v. State

132 So. 3d 40, 38 Fla. L. Weekly Supp. 756, 2013 WL 5659482, 2013 Fla. LEXIS 2287

Supreme Court of Florida | Filed: Oct 17, 2013 | Docket: 60238469

Cited 7 times | Published

is a schedule II regulated substance under section 893.03(2), Florida Statutes (2012). Foster also contends

Stabler v. State

990 So. 2d 1258, 2008 WL 4361853

District Court of Appeal of Florida | Filed: Sep 26, 2008 | Docket: 1292807

Cited 7 times | Published

than 150 kilograms, of cocaine in violation of section 893.03(2)(a)4, Florida Statutes (2005). Prior to trial

Bowen v. State

685 So. 2d 942, 1996 WL 728341

District Court of Appeal of Florida | Filed: Dec 20, 1996 | Docket: 1735141

Cited 7 times | Published

REVERSED. COBB and THOMPSON, JJ., concur. NOTES [1] § 893.03(2)(a)(4), Fla. Stat. (1993). [2] However, a recent

Young v. State

439 So. 2d 306

District Court of Appeal of Florida | Filed: Oct 6, 1983 | Docket: 1265947

Cited 7 times | Published

Cannabis is a controlled substance named in section 893.03(1)(c), Florida Statutes (1981). Section 893

O'HARA v. State

964 So. 2d 839, 2007 WL 2713539

District Court of Appeal of Florida | Filed: Sep 19, 2007 | Docket: 1223009

Cited 6 times | Published

893.03." Hydrocodone is one of those substances. § 893.03(2)(a)(1)(j), (3)(c)(3)-(4). Therefore, hydrocodone

Newmans v. State, Div. of Retirement

701 So. 2d 573, 1997 WL 574613

District Court of Appeal of Florida | Filed: Sep 18, 1997 | Docket: 1470321

Cited 6 times | Published

controlled substance. Under Florida Statutes Section 893.03, marijuana was a controlled substance. ...

United States v. Frazier

89 F.3d 1501, 1996 WL 403100

Court of Appeals for the Eleventh Circuit | Filed: Aug 2, 1996 | Docket: 64025827

Cited 6 times | Published

628 n. 1 (11th Cir.1995). . Florida Statutes § 893.03 sets forth the state's standards and schedules

LJ v. State

578 So. 2d 360, 1991 WL 50224

District Court of Appeal of Florida | Filed: Apr 9, 1991 | Docket: 441020

Cited 6 times | Published

compound, derivative, or preparation of cocaine... ." § 893.03(2)(a)(4), Fla. Stat. (1989). It is well settled

Hand v. State

334 So. 2d 601

Supreme Court of Florida | Filed: Jun 4, 1976 | Docket: 1712422

Cited 6 times | Published

Comprehensive Drug Abuse Prevention and Control Act, Section 893.03(3)(a), Fla. Stat. (1975). [2] De Jong v. Pallotto

Mullis v. State

79 So. 3d 747, 2011 Fla. App. LEXIS 14233, 2011 WL 3962910

District Court of Appeal of Florida | Filed: Sep 9, 2011 | Docket: 2356189

Cited 5 times | Published

13(7)(a)(8) as the "doctor shopping" statute). [3] § 893.03(2)(a)(1)(o). [4] The circuit court's order states

Rivera v. State

917 So. 2d 210, 2005 WL 2175443

District Court of Appeal of Florida | Filed: Sep 9, 2005 | Docket: 1509623

Cited 5 times | Published

PETERSON and SAWAYA, JJ., concur. NOTES [1] § 893.03(2)(a)4, Fla. Stat. (2002). [2] § 90.803(6), Fla

Fink v. Holt

609 So. 2d 1333, 1992 WL 324724

District Court of Appeal of Florida | Filed: Nov 12, 1992 | Docket: 1738057

Cited 5 times | Published

that the Sheriff established probable cause. Section 893.03(2) begins with a legislative recognition that

State v. Anders

596 So. 2d 463, 1992 WL 43260

District Court of Appeal of Florida | Filed: Mar 11, 1992 | Docket: 1358904

Cited 5 times | Published

of Florida Statute 893.135(1)(b)(3) and Florida Statute 893.03(2)(a)(4). ANDERS' conviction would carry

State v. Austin

532 So. 2d 19, 1988 WL 89697

District Court of Appeal of Florida | Filed: Sep 1, 1988 | Docket: 450673

Cited 5 times | Published

twenty-eight grams or more of cocaine as described in section 893.03(2)(a)(4) or of any mixture containing cocaine

Dudley v. State

511 So. 2d 1052, 12 Fla. L. Weekly 1950

District Court of Appeal of Florida | Filed: Aug 11, 1987 | Docket: 1338694

Cited 5 times | Published

mandatory sentence of fifteen years imprisonment. § 893.03(2)(a), Fla. Stat. (1985). Brown had apparently

Vanhoosen v. State

469 So. 2d 230, 10 Fla. L. Weekly 1336

District Court of Appeal of Florida | Filed: May 29, 1985 | Docket: 1272279

Cited 5 times | Published

controlled substances named or described in section 893.03, Florida Statutes; subsequent laboratory analysis

Ramon Duran Guillen v. U.S. Attorney General

910 F.3d 1174

Court of Appeals for the Eleventh Circuit | Filed: Dec 13, 2018 | Docket: 8405756

Cited 4 times | Published

law. 1 Compare Fla. Stat. § 893.03 with 21 U.S.C. § 812 and

State v. Young

936 So. 2d 725, 2006 WL 2366408

District Court of Appeal of Florida | Filed: Aug 17, 2006 | Docket: 1651105

Cited 4 times | Published

than 20 grams of cannabis, in violation of section 893.03(1)(c) & 893.13(6)(b), Florida Statutes (2004);

White v. State

680 So. 2d 550, 1996 WL 419328

District Court of Appeal of Florida | Filed: Jul 29, 1996 | Docket: 1201899

Cited 4 times | Published

derivatives in its list of controlled substances. § 893.03(2)(a)4, Fla. Stat. (1993). Thus, the Forfeiture

Walter v. SCH. BD. OF INDIAN RIVER CTY.

518 So. 2d 1331, 13 Fla. L. Weekly 48, 1987 Fla. App. LEXIS 11692, 1987 WL 3026

District Court of Appeal of Florida | Filed: Dec 23, 1987 | Docket: 1778147

Cited 4 times | Published

personnel. Marijuana or cannabis, is included in section 893.03(1)(c), Florida Statutes (1985), among the hallucinogenic

Rogers v. State Bd. of Med. Examiners

371 So. 2d 1037

District Court of Appeal of Florida | Filed: Jan 9, 1979 | Docket: 1785677

Cited 4 times | Published

substances such as those enumerated in Florida Statute 893.03, nor has there been any allegation or proof

Sobel v. State

349 So. 2d 747

District Court of Appeal of Florida | Filed: Aug 30, 1977 | Docket: 1225938

Cited 4 times | Published

schedules of the controlled substances statute, Section 893.03, Florida Statutes, the defendant argues that

Hendley v. State

58 So. 3d 296, 2011 WL 561407

District Court of Appeal of Florida | Filed: Feb 18, 2011 | Docket: 60299302

Cited 3 times | Published

amends. IV, XIV; art. I, § 12, Fla. Const. . See § 893.03(2)(a)(l)(o). .The bulletin indicated that Mr

Hernandez v. State

56 So. 3d 752, 35 Fla. L. Weekly Supp. 714, 2010 Fla. LEXIS 2083, 2010 WL 4977481

Supreme Court of Florida | Filed: Dec 9, 2010 | Docket: 60298635

Cited 3 times | Published

weight, is a felony of the second degree. See § 893.03(2)(a)4., Fla. Stat. (2002) (classifying cocaine

Nicholson v. State

33 So. 3d 107, 2010 Fla. App. LEXIS 5545, 2010 WL 1656857

District Court of Appeal of Florida | Filed: Apr 27, 2010 | Docket: 1648971

Cited 3 times | Published

grams of hydrocodone, a controlled substance. § 893.03(2)(a)1.j., Fla. Stat. (2007). The State did not

Aumuller v. State

944 So. 2d 1137, 2006 WL 3524033

District Court of Appeal of Florida | Filed: Dec 8, 2006 | Docket: 1649572

Cited 3 times | Published

distribution of any substance controlled under Florida Statute 893.03(1) by Michael Aumuller, a person 18 years

Paey v. State

943 So. 2d 919, 2006 WL 3498319

District Court of Appeal of Florida | Filed: Dec 6, 2006 | Docket: 1526771

Cited 3 times | Published

oxycodone to be a potentially dangerous substance. Section 893.03 contains standards and schedules for controlled

Barnes v. State

864 So. 2d 1200, 2004 WL 61239

District Court of Appeal of Florida | Filed: Jan 14, 2004 | Docket: 1425675

Cited 3 times | Published

controlled substance listed under Schedule II in section 893.03(2)(a)1.j., Florida Statutes (1999). Subject

Sowell v. State

738 So. 2d 333, 1998 WL 64945

District Court of Appeal of Florida | Filed: Feb 19, 1998 | Docket: 1752221

Cited 3 times | Published

use of certain controlled substances under section 893.03, Fla. Stat. This statute catalogs various controlled

Craig v. State

643 So. 2d 50, 1994 WL 515729

District Court of Appeal of Florida | Filed: Sep 23, 1994 | Docket: 1492942

Cited 3 times | Published

See § 893.13(1)(a)1, Fla. Stat. (1993). See also § 893.03(2)(a)4, Fla. Stat. (1993). [2] See Gedeon v.

State v. Lite

592 So. 2d 1202, 1992 WL 7213

District Court of Appeal of Florida | Filed: Jan 22, 1992 | Docket: 1429648

Cited 3 times | Published

guilty to possession of cocaine in violation of section 893.03(2)(a)4, Florida Statutes (1990). Pursuant to

Ralston v. State

555 So. 2d 443, 1990 WL 2687

District Court of Appeal of Florida | Filed: Jan 17, 1990 | Docket: 2573406

Cited 3 times | Published

for trafficking in cocaine in violation of section 893.03(2)(a)(4), Florida Statutes (1987), a sentence

Williams v. State

547 So. 2d 710, 1989 WL 89670

District Court of Appeal of Florida | Filed: Aug 11, 1989 | Docket: 1738784

Cited 3 times | Published

possession of cocaine and further cites to section 893.03(2)(a)4, which lists cocaine as a schedule two

Thompson v. State

374 So. 2d 91

District Court of Appeal of Florida | Filed: Aug 17, 1979 | Docket: 1523335

Cited 3 times | Published

in excess of 100 pounds in violation *92 of Section 893.03(1)(c), Florida Statutes (1977). Thompson entered

In re Standard Jury Instructions in Criminal Cases-Rreport No. 2012-08

131 So. 3d 692, 2013 WL 6124277

Supreme Court of Florida | Filed: Nov 21, 2013 | Docket: 60238156

Cited 2 times | Published

substance as outlined in Schedule [I][II] of Florida Statute 893.03 to any person for the purpose of: a. [using

Richards v. State

37 So. 3d 925, 2010 Fla. App. LEXIS 8184, 2010 WL 2292116

District Court of Appeal of Florida | Filed: Jun 9, 2010 | Docket: 1239894

Cited 2 times | Published

"controlled substance named or described in ... § 893.03[]." The Information alleged he intended to sell

Taylor v. State

848 So. 2d 1191, 2003 WL 21297235

District Court of Appeal of Florida | Filed: Jun 6, 2003 | Docket: 1712310

Cited 2 times | Published

AFFIRMED. GRIFFIN and PALMER, JJ., concur. NOTES [1] § 893.03(1)(c)(7), Florida Statutes (2002). [2] See, Florida

State v. Travis

808 So. 2d 194, 2002 WL 58552

Supreme Court of Florida | Filed: Jan 17, 2002 | Docket: 1474048

Cited 2 times | Published

schedule II controlled substance listed in section 893.03(2)(a)1.o., Florida Statutes (1997). Travis

Eagle v. State

772 So. 2d 1, 2000 WL 898070

District Court of Appeal of Florida | Filed: Jul 7, 2000 | Docket: 1435578

Cited 2 times | Published

more than 15 milligrams per dosage unit ...." § 893.03(3)(c)4. Consequently, the supreme court concluded

Ramos v. State

529 So. 2d 807, 1988 WL 82677

District Court of Appeal of Florida | Filed: Aug 10, 1988 | Docket: 432331

Cited 2 times | Published

of 28 grams or more of cocaine as described in § 893.03(2)(a)4 or of any mixture containing cocaine is

Albert v. Salce

439 So. 2d 339

District Court of Appeal of Florida | Filed: Oct 18, 1983 | Docket: 1265866

Cited 2 times | Published

certain controlled substances described in Section 893.03(1)(a) or (b) is guilty of a first-degree felony

Nealy v. State

400 So. 2d 95

District Court of Appeal of Florida | Filed: Jun 9, 1981 | Docket: 1263441

Cited 2 times | Published

Reversed. NOTES [1] § 322.34 Fla. Stat. (1979). [2] § 893.03(2)(a)(4) Fla. Stat. (1979). [3] Appellant had

State v. Casesa

392 So. 2d 1022

District Court of Appeal of Florida | Filed: Jan 28, 1981 | Docket: 1268429

Cited 2 times | Published

of cannabis, a substance controlled by Florida Statute 893.03(1)(c), which act is prohibited and declared

Marshall v. State

381 So. 2d 276

District Court of Appeal of Florida | Filed: Feb 27, 1980 | Docket: 1758138

Cited 2 times | Published

known as Hashish, a substance controlled by Florida Statute 893.03(1)(c). Two points have been raised on appeal

Bourassa v. State

366 So. 2d 12

Supreme Court of Florida | Filed: Oct 12, 1978 | Docket: 1228430

Cited 2 times | Published

under five grams of cannabis, in violation of Section 893.03(1)(c) and Section 893.13(1)(f), Florida Statutes

Wright v. State

351 So. 2d 1127

District Court of Appeal of Florida | Filed: Nov 17, 1977 | Docket: 1247482

Cited 2 times | Published

controlled substance, named or described in Section 893.03(1)(c), Florida Statutes, to-wit: more than

Franklin v. State

346 So. 2d 137

District Court of Appeal of Florida | Filed: May 27, 1977 | Docket: 1411169

Cited 2 times | Published

controlled substance is named or described in § 893.03(1)(c) [which includes cannabis], the possessor

Arm Ventures, LLC

564 B.R. 77, 26 Fla. L. Weekly Fed. B 221, 2017 Bankr. LEXIS 416

United States Bankruptcy Court, S.D. Florida. | Filed: Feb 14, 2017 | Docket: 65789500

Cited 1 times | Published

classified as a Schedule III Drug. See Fla. Stat. § 893.03(2)—(3). According to the Debtor, both Modern Pharmacy

Oleckna v. Daytona Discount Pharmacy

162 So. 3d 178, 2015 Fla. App. LEXIS 1561, 2015 WL 477841

District Court of Appeal of Florida | Filed: Feb 6, 2015 | Docket: 60247439

Cited 1 times | Published

Alprazolam is a Schedule IV controlled substance. See § 893.03, Fla. Stat. (2010). "A substance listed in Schedule

In Re STANDARD JURY INSTRUCTIONS IN CRIMINAL CASES—REPORT NO. 2013-05

153 So. 3d 192, 2014 WL 6977938

Supreme Court of Florida | Filed: Dec 11, 2014 | Docket: 2613862

Cited 1 times | Published

defendant possessed a controlled substance listed in § 893.03(l)(c)46.-50., 114.-142., 151.-159, or 166.-169

Tyler v. State

107 So. 3d 547, 2013 WL 673647, 2013 Fla. App. LEXIS 2994

District Court of Appeal of Florida | Filed: Feb 26, 2013 | Docket: 60228749

Cited 1 times | Published

controlled substance named or described in Section 893.03(Z )(c), Florida Statutes, to-wit: not more

Shelton v. Secretary, Department of Corrections

802 F. Supp. 2d 1289, 2011 U.S. Dist. LEXIS 86898, 2011 WL 3236040

District Court, M.D. Florida | Filed: Jul 27, 2011 | Docket: 65975126

Cited 1 times | Published

controlled substance as defined in Schedule I, Fla. Stat. 893.03(1), is a second degree felony, ordinarily

Horne v. State

35 So. 3d 40, 2010 Fla. App. LEXIS 1807, 2010 WL 567196

District Court of Appeal of Florida | Filed: Feb 19, 2010 | Docket: 1646407

Cited 1 times | Published

controlled substance named or described in section 893.03(2)(c)(4), and delivery of methamphetamine is

State v. Williams

873 So. 2d 602, 2004 WL 1175241

District Court of Appeal of Florida | Filed: May 28, 2004 | Docket: 1732988

Cited 1 times | Published

SAWAYA, C.J., and TORPY, J., concur. NOTES [1] § 893.03(2)(a)4., Fla. Stat. [2] § 322.34(2)(a), Fla.

Walls v. State

814 So. 2d 1235, 2002 WL 832202

District Court of Appeal of Florida | Filed: May 3, 2002 | Docket: 1369090

Cited 1 times | Published

THOMPSON, CJ., and PALMER, J., concur. NOTES [1] § 893.03(2)(a)(4), Fla. Stat. (2000). [2] Fla. R.App.

State v. Farley

788 So. 2d 338, 2001 WL 558095

District Court of Appeal of Florida | Filed: May 25, 2001 | Docket: 1286577

Cited 1 times | Published

(1998) and possession of cocaine in violation of section 893.03(2)(a)(4), Florida Statutes (1998). The State

Shearin v. State

755 So. 2d 800, 2000 WL 377468

District Court of Appeal of Florida | Filed: Apr 14, 2000 | Docket: 1699413

Cited 1 times | Published

which are schedule IV controlled substances. See § 893.03(4)(a, o), Fla. Stat. (1997). As a result, the

State v. Sowell

734 So. 2d 421, 1999 WL 350506

Supreme Court of Florida | Filed: Jun 3, 1999 | Docket: 1731042

Cited 1 times | Published

CHAPTER 93-92, LAWS OF FLORIDA, AMENDMENT TO SECTION 893.03(1)(D), FLORIDA STATUTES, EFFECTS A CLEAR AND

Gainer v. State

671 So. 2d 240, 1996 WL 160795

District Court of Appeal of Florida | Filed: Apr 9, 1996 | Docket: 1671999

Cited 1 times | Published

controlled substance (cocaine, as defined in section 893.03, Florida Statutes (1993)) in violation of section

State v. McGee

494 So. 2d 255, 11 Fla. L. Weekly 1924

District Court of Appeal of Florida | Filed: Sep 3, 1986 | Docket: 452411

Cited 1 times | Published

Stat. (1985). Cannabis is a controlled substance. § 893.03(1)(c)3, Fla. Stat. (1985). One who possesses 20

Thompson v. DEPT. OF PROFESSIONAL

488 So. 2d 103, 11 Fla. L. Weekly 937

District Court of Appeal of Florida | Filed: Apr 22, 1986 | Docket: 1287330

Cited 1 times | Published

Demerol (a Schedule II controlled substance, Section 893.03, Florida Statutes) and 18 prescriptions of

G. E. G. v. State

417 So. 2d 975, 1982 Fla. LEXIS 2479

Supreme Court of Florida | Filed: Jul 15, 1982 | Docket: 64591599

Cited 1 times | Published

whether an object is a controlled substance under section 893.03, Florida Statutes (1981). It is the testimony

Woodward v. State

379 So. 2d 664

District Court of Appeal of Florida | Filed: Jan 16, 1980 | Docket: 1276956

Cited 1 times | Published

pounds of cannabis, a proscribed drug under section 893.03(1)(c), Florida Statutes (1977). In Hamilton

State v. Cheatham

376 So. 2d 1167

Supreme Court of Florida | Filed: Nov 8, 1979 | Docket: 2556372

Cited 1 times | Published

consolidated appeals from trial court orders declaring section 893.03(1)(c), Florida Statutes (1978 Supp.), unconstitutional

Thomas Andrew Vana, Jr. v. State of Florida

District Court of Appeal of Florida | Filed: Sep 5, 2025 | Docket: 71276001

Published

893.13(1)(a)1, (c)1.; § 893.03(1)(a)63., Fla. Stat. (2018) (fentanyl); § 893.03(1)(b)11., Fla. Stat.

State of Florida v. Powell

District Court of Appeal of Florida | Filed: Aug 6, 2025 | Docket: 71038918

Published

controlled substance, a third-degree felony, under section 893.03, Florida Statutes; one count of bringing a

Ernest Lawson v. State of Florida

District Court of Appeal of Florida | Filed: Jul 23, 2025 | Docket: 70891682

Published

s. 893.03.” § 893.02(4), Fla. Stat. (2023). Section 893.03, Florida Statutes (2023), lists the different

Lavoski Jackson v. State of Florida

District Court of Appeal of Florida | Filed: Apr 16, 2025 | Docket: 69899470

Published

was convicted of possessing is not listed in section 893.03(1)(c)191., Florida Statutes (2023), under which

Campbell v. State of Florida

District Court of Appeal of Florida | Filed: Mar 26, 2025 | Docket: 69792800

Published

classified as a Schedule I controlled substance. § 893.03(1)(c)7, Fla. Stat. Up until July 2019, cannabis

Rivera v. State of Florida

District Court of Appeal of Florida | Filed: Nov 8, 2024 | Docket: 69354846

Published

possession of a fentanyl derivative as identified in section 893.03(1)(a)62, Florida Statutes (2022), and in count

The State of Florida v. Daniel Arshadnia

District Court of Appeal of Florida | Filed: Dec 20, 2023 | Docket: 68103690

Published

supervision does not meet accepted safety standards.” § 893.03(1), Fla. Stat.

United States v. Clifford Laines, Jr.

Court of Appeals for the Eleventh Circuit | Filed: Jun 6, 2023 | Docket: 67479768

Published

STAT. § 893.13(1)(a)(1) (1991); see id. § 893.03 (controlled substance schedule). Laines argues

United States v. Clifford Laines, Jr.

Court of Appeals for the Eleventh Circuit | Filed: Jun 6, 2023 | Docket: 67479768

Published

STAT. § 893.13(1)(a)(1) (1991); see id. § 893.03 (controlled substance schedule). Laines argues

United States v. Eugene Jackson

Court of Appeals for the Eleventh Circuit | Filed: Dec 13, 2022 | Docket: 66631832

Published

preparation of cocaine or ecgonine.” Id. § 893.03(2)(a)(4) (1998); see also id. (2004). It’s clear

STATE OF FLORIDA v. ANTHONY LEVERN WAITERS

District Court of Appeal of Florida | Filed: Sep 23, 2022 | Docket: 65370801

Published

multiple controlled substances enumerated under section 893.03 "when such substance or mixture is proven

United States v. Eugene Jackson

Court of Appeals for the Eleventh Circuit | Filed: Jun 10, 2022 | Docket: 63381032

Published

was convicted of his cocaine-related offenses, § 893.03(2)(a)(4) set forth the formulations encompassed

United States v. Eugene Jackson

Court of Appeals for the Eleventh Circuit | Filed: Jun 10, 2022 | Docket: 63375807

Published

was convicted of his cocaine-related offenses, § 893.03(2)(a)(4) set forth the formulations encompassed

JOHNNY RAY GRAHAM v. STATE OF FLORIDA

District Court of Appeal of Florida | Filed: May 11, 2022 | Docket: 63301701

Published

Cocaine is a substance named and described in section 893.03(2). A counterfeit controlled substance is defined

Solomon Chamu v. U.S. Attorney General

Court of Appeals for the Eleventh Circuit | Filed: Jan 26, 2022 | Docket: 62630576

Published

[cocaine’s] stereoisomers.” Fla. Stat. § 893.03(2)(a)(4) (2003). The federal definition, at least

STATE OF FLORIDA v. LUCAS STEVENSON

District Court of Appeal of Florida | Filed: Dec 2, 2020 | Docket: 18706930

Published

evidence that the State charged him with violating section 893.03(1)(c)190.a., governing “synthetic cannabinoids

In Re: Standard Jury Instructions in Criminal Cases-Report 2018-12.

272 So. 3d 243

Supreme Court of Florida | Filed: May 30, 2019 | Docket: 15696547

Published

Delivery because the definition of "delivery" in § 893.03(6), Fla. Stat. includes the attempt to transfer

In Re: Standard Jury Instructions in Criminal Cases-Report 2018-14.

267 So. 3d 980

Supreme Court of Florida | Filed: Apr 11, 2019 | Docket: 14917537

Published

substance as outlined in Schedule [I] [II] of Florida Statute 893.03 to any person for the purpose of exploitation

TRAVIS MONTEZ EDWARDS v. STATE OF FLORIDA

268 So. 3d 849

District Court of Appeal of Florida | Filed: Mar 15, 2019 | Docket: 14717608

Published

described" in various subsections of section 893.03. Under section 893.13(1)(a), the type of drug

Kramer Forest v. State of Florida

257 So. 3d 603

District Court of Appeal of Florida | Filed: Oct 18, 2018 | Docket: 8048726

Published

defined as a Schedule I controlled substance. § 893.03(1)(c)7., Fla. Stat. (2016). A Schedule I substance

BERNARD DAVIS v. STATE OF FLORIDA

244 So. 3d 312

District Court of Appeal of Florida | Filed: Apr 18, 2018 | Docket: 6366324

Published

controlled substance named or described in section 893.03(1)(c) commits a felony of the third degree

In Re: Standard Jury Instructions in Criminal Cases-Report 2016-09

216 So. 3d 497

Supreme Court of Florida | Filed: Apr 27, 2017 | Docket: 5813561

Published

Delivery because the definition of “delivery” in § 893.03(6), Fla. Stat. includes the attempt to transfer

Brevard County Sheriff's Office v. Brown

208 So. 3d 1281, 2017 WL 456933, 2017 Fla. App. LEXIS 1257

District Court of Appeal of Florida | Filed: Feb 3, 2017 | Docket: 4583365

Published

Methamphetamine is a controlled substance. See § 893.03(2)(c)4., Fla. Stat. (2015). A pipe containing

In Re STANDARD JURY INSTRUCTIONS IN CRIMINAL CASES—INSTRUCTION 29.24

200 So. 3d 754, 2016 WL 4916757

Supreme Court of Florida | Filed: Sep 15, 2016 | Docket: 4422156

Published

substance as outlined in Schedule [I] [II] of Florida Statute 893.03 to any person for the purpose of exploitation

Ryan Wilder v. State of Florida

194 So. 3d 1050, 2016 Fla. App. LEXIS 9223, 2016 WL 3266119

District Court of Appeal of Florida | Filed: Jun 15, 2016 | Docket: 3078541

Published

of.. : methamphetamine .as described in section 893.03(2)(c)4., or of any mixture[

In Re: Standard Jury Instructions in Criminal Cases - Report No. 2015-03 – Corrected Opinion

Supreme Court of Florida | Filed: May 19, 2016 | Docket: 3065478

Published

defendant possessed a controlled substance listed in § 893.03(1)(c)46.–50., 114.–142., 151.–159, or 166.–16973

In Re STANDARD JURY INSTRUCTIONS IN CRIMINAL CASES—REPORT NO. 2015-03

191 So. 3d 291, 2016 WL 1375710

Supreme Court of Florida | Filed: Apr 7, 2016 | Docket: 3051607

Published

defendant possessed a controlled substance listed in § 893.03(l)(c)46.;50., 114.442., 161.469, or 166.46973

Kevin Osorio v. State of Florida

186 So. 3d 601, 2016 Fla. App. LEXIS 3134, 2016 WL 803515

District Court of Appeal of Florida | Filed: Mar 2, 2016 | Docket: 3040734

Published

classified as schedule I controlled substances. § 893.03(l)(d), Fla. Stat. (2011). 3 .

Crooms v. State

182 So. 3d 780, 2015 Fla. App. LEXIS 19512, 2015 WL 9491839

District Court of Appeal of Florida | Filed: Dec 31, 2015 | Docket: 60252819

Published

provided in s. 775.082, s. 775.083, or s. 775.084. Section 893.03, Florida Statutes (2015), contains an exhaustive

In Re STANDARD JURY INSTRUCTIONS IN CRIMINAL CASES-REPORT NO. 2014-08

176 So. 3d 938, 2015 WL 5853925

Supreme Court of Florida | Filed: Oct 8, 2015 | Docket: 2866126

Published

substance as outlined in Schedule [I] [II] of Florida Statute 893.03 to any person for the purpose of exploitation

Gregory Gun v. State of Florida

171 So. 3d 184, 2015 Fla. App. LEXIS 11406, 2015 WL 4557049

District Court of Appeal of Florida | Filed: Jul 29, 2015 | Docket: 2679170

Published

legislature amended the pertinent statute, section 893.03, “to add additional synthetic cannabinoid[s]

Moore v. State

172 So. 3d 491, 2015 Fla. App. LEXIS 10951, 2015 WL 4464689

District Court of Appeal of Florida | Filed: Jul 21, 2015 | Docket: 60250071

Published

Oxycodone with the intent to sell, in violation of section 893.03(l)(a), Florida Statutes, and one count of selling

State v. Toussaint

168 So. 3d 308, 2015 Fla. App. LEXIS 9992, 2015 WL 4002453

District Court of Appeal of Florida | Filed: Jul 2, 2015 | Docket: 60248637

Published

the Florida Rules of Appellate Procedure. . § 893.03(l)(c)7, Fla. Stat. (2013). . §§ 893.13(6)(a);

Gregroy Gun v. State of Florida

District Court of Appeal of Florida | Filed: Apr 8, 2015 | Docket: 2679415

Published

among the controlled substances proscribed in section 893.03, Florida Statutes (2013), and therefore testimony

In re Standard Jury Instructions in Criminal Cases-Instructions 25.9-25.13

112 So. 3d 1211, 2013 WL 1664379

Supreme Court of Florida | Filed: Apr 18, 2013 | Docket: 60230991

Published

Delivery because the definition of “delivery” in § 893.03(6) Fla. Stat. includes the attempt to transfer

McMillon v. State

109 So. 3d 886, 2013 WL 1163466, 2013 Fla. App. LEXIS 4752

District Court of Appeal of Florida | Filed: Mar 22, 2013 | Docket: 60229849

Published

of cocaine in violation of Florida Statutes section 893.03(2)(a)(4) (2011). After a trial, a jury found

Hollingshead v. State

80 So. 3d 424, 2012 WL 469808, 2012 Fla. App. LEXIS 2267

District Court of Appeal of Florida | Filed: Feb 15, 2012 | Docket: 60305705

Published

(effective July 1, 2001), which added language to section 893.03(3) and created 893.135(6), Florida Statutes

McGrill v. State

82 So. 3d 130, 2012 Fla. App. LEXIS 1780, 2012 WL 385647

District Court of Appeal of Florida | Filed: Feb 8, 2012 | Docket: 60306090

Published

with possession of cocaine in violation of section 893.03(2)(a)(4), Florida Statutes (2008), and section

Cox v. State

75 So. 3d 325, 2011 Fla. App. LEXIS 16275, 2011 WL 4905762

District Court of Appeal of Florida | Filed: Oct 17, 2011 | Docket: 2357477

Published

Dilaudid, is a Schedule II controlled substance. § 893.03(2)(a)l.k., Fla. Stat. (2008); Todd v. State, 648

Rodriguez v. State

67 So. 3d 326, 2011 Fla. App. LEXIS 10561, 2011 WL 3311753

District Court of Appeal of Florida | Filed: Jul 6, 2011 | Docket: 2356101

Published

III narcotic, and a controlled substance. See § 893.03, Fla. Stat. (2010). "A substance listed in Schedule

Signature Pharmacy, Inc. v. Soares

717 F. Supp. 2d 1276, 2010 U.S. Dist. LEXIS 57714, 2010 WL 2330279

District Court, M.D. Florida | Filed: Jun 10, 2010 | Docket: 2404377

Published

writing prescriptions in violation of FLA. STAT. § 893.03(8).[35] This Court has laboriously examined each

Terry v. State

14 So. 3d 264, 2009 Fla. App. LEXIS 10366, 2009 WL 2243812

District Court of Appeal of Florida | Filed: Jul 29, 2009 | Docket: 1158517

Published

controlled substance, to-wit: Cocaine, contrary to F.S. 893.03(2)(a)(4), F.S. 893.13(2)(a) and F.S. 777.04(2)

State v. McCartney

1 So. 3d 326, 2009 Fla. App. LEXIS 329, 2009 WL 129607

District Court of Appeal of Florida | Filed: Jan 21, 2009 | Docket: 1653932

Published

methadone was not a Schedule I drug set out in section 893.03(1). The state acknowledged that methadone is

Jones v. State

957 So. 2d 115, 2007 WL 1427453

District Court of Appeal of Florida | Filed: May 16, 2007 | Docket: 1679262

Published

may see, possibly statue (sic), Florida Law F.S. 893.03?" Again, both defense counsel and prosecution

Burgos v. State

939 So. 2d 219, 2006 Fla. App. LEXIS 16930, 31 Fla. L. Weekly Fed. D 2539

District Court of Appeal of Florida | Filed: Oct 11, 2006 | Docket: 64847177

Published

or more and less than 200 grams pursuant to section 893.03(2)(a)4., Florida Statutes (2003), or any mixture

Gray v. State

915 So. 2d 254, 2005 Fla. App. LEXIS 18883, 2005 WL 3239244

District Court of Appeal of Florida | Filed: Dec 2, 2005 | Docket: 64841023

Published

acid, a schedule I controlled substance. See § 893.03(1)(d)(3), Fla. Stat. (2005). . § 893.135(4)

State v. Quetglas

901 So. 2d 360, 2005 Fla. App. LEXIS 6611, 2005 WL 1046944

District Court of Appeal of Florida | Filed: May 6, 2005 | Docket: 64838030

Published

schedule II controlled substance listed in section 893.03(2)(b)(ll), Florida Statutes (2000). Quetglas

Nweze v. State

754 So. 2d 119, 2000 Fla. App. LEXIS 2950, 2000 WL 282322

District Court of Appeal of Florida | Filed: Mar 17, 2000 | Docket: 64796141

Published

. § 893.13(l)(a)(l), Fla. Stat. (1997). . § 893.03(2)(a)(4), Fla. Stat. (1997). . § 893.13(6)(a)

Nelson v. State

707 So. 2d 405, 1998 Fla. App. LEXIS 2422, 1998 WL 106982

District Court of Appeal of Florida | Filed: Mar 13, 1998 | Docket: 64779621

Published

in violation of section 893.13(l)(a)l., and section 893.03(2)(a)4., Florida Statutes (1995). We vacate

Watkins v. State

701 So. 2d 592, 1997 Fla. App. LEXIS 11867, 1997 WL 644731

District Court of Appeal of Florida | Filed: Oct 21, 1997 | Docket: 64776770

Published

inclusion of cannabis as a schedule I drug in section 893.03(1), Florida Statutes (1993), is unconstitutional

Cuva v. State

687 So. 2d 274, 1997 Fla. App. LEXIS 99, 1997 WL 7125

District Court of Appeal of Florida | Filed: Jan 10, 1997 | Docket: 64770681

Published

and HARRIS, JJ., concur. . § 893.03(l)(c)4, Fla. Stat (1993). . § 893.03(l)(c), Fla. Stat. (1993).

Cox v. State

687 So. 2d 25, 1996 Fla. App. LEXIS 13229, 1996 WL 729753

District Court of Appeal of Florida | Filed: Dec 20, 1996 | Docket: 64770616

Published

GOSHORN, JJ., concur. . § 810.06, Fla. Stat. . § 893.03, Fla. Stat. . § 893.13, Fla. Stat. . § 893

Harris v. State

655 So. 2d 1179, 1995 Fla. App. LEXIS 5070, 1995 WL 276084

District Court of Appeal of Florida | Filed: May 12, 1995 | Docket: 64756666

Published

A controlled substance named or described in § 893.03(l)(a), (l)(b), (l)(d), (2)(a), or (2)(b) commits

State v. Ingleton

653 So. 2d 443, 1995 Fla. App. LEXIS 3309, 1995 WL 137070

District Court of Appeal of Florida | Filed: Mar 31, 1995 | Docket: 64755475

Published

substance under section 893.03(1), Florida Statutes, cocaine as described in section 893.03(2)(a)4, Florida

Todd v. State

648 So. 2d 249, 1994 Fla. App. LEXIS 12551, 1994 WL 715196

District Court of Appeal of Florida | Filed: Dec 28, 1994 | Docket: 64753245

Published

like hydromorphone, specifically designated in section 893.03(2)(a), he argues that he could therefore not

State v. Lee

647 So. 2d 810, 19 Fla. L. Weekly Supp. 498, 1994 Fla. LEXIS 1526, 1994 WL 540692

Supreme Court of Florida | Filed: Oct 6, 1994 | Docket: 64753008

Published

THEREOF of a controlled substance defined in Section 893.03, contrary to Section 893.135, Florida Statutes

State v. Collins

639 So. 2d 633, 1994 Fla. App. LEXIS 6412, 1994 WL 287002

District Court of Appeal of Florida | Filed: Jun 29, 1994 | Docket: 64749634

Published

classification of controlled substances referred to in section 893.03, Florida Statutes (1993), as a Schedule II

M.H. v. State

622 So. 2d 105, 1993 Fla. App. LEXIS 7895, 1993 WL 277185

District Court of Appeal of Florida | Filed: Jul 27, 1993 | Docket: 64698009

Published

00 was cocaine, a substance made illegal by section 893.03(2)(a). Section 893.13(l)(i) provides: Except

Whitfield v. State

620 So. 2d 1027, 1993 Fla. App. LEXIS 5460, 1993 WL 157832

District Court of Appeal of Florida | Filed: May 17, 1993 | Docket: 64697435

Published

or obtained a controlled substance listed in section 893.03, Florida Statutes. The trial court should have

Wright v. State

617 So. 2d 857, 1993 Fla. App. LEXIS 4989, 1993 WL 144085

District Court of Appeal of Florida | Filed: May 5, 1993 | Docket: 64695908

Published

“penicillin is an amphetamine.” The order cites section 893.-03(2)(c)(2), Florida Statutes (1991), for this

State v. Diloreto

600 So. 2d 25, 1992 WL 115787

District Court of Appeal of Florida | Filed: Jul 1, 1992 | Docket: 1527861

Published

statute to include all substances listed in section 893.03(1)(b) or (2)(a), notwithstanding the explicit

State v. Adams

600 So. 2d 1302, 1992 Fla. App. LEXIS 6755, 1992 WL 143601

District Court of Appeal of Florida | Filed: Jun 26, 1992 | Docket: 64668562

Published

methamphetamine and ephedrine, a substance controlled by section 893.03(2)(c)3, Florida Statutes (1989). On February

State v. Cruz

582 So. 2d 20, 1991 Fla. App. LEXIS 4976, 1991 WL 87964

District Court of Appeal of Florida | Filed: May 30, 1991 | Docket: 64659959

Published

free of any controlled substances named in Section 893.03 F.S.; the C.I. was then given thirty dollars

Stidham v. State

579 So. 2d 319, 1991 Fla. App. LEXIS 4163, 1991 WL 72086

District Court of Appeal of Florida | Filed: May 9, 1991 | Docket: 64658632

Published

28 grams or more of cocaine as described in section 893.03(2)(a)4. or of any mixture containing cocaine

L.J. v. State

578 So. 2d 360, 1991 Fla. App. LEXIS 3292

District Court of Appeal of Florida | Filed: Apr 9, 1991 | Docket: 64658241

Published

compound, derivative, or preparation of co-caine_” § 893.03(2)(a)(4), Fla.Stat. (1989). It is well settled

Rivero v. State

573 So. 2d 427, 1991 Fla. App. LEXIS 661, 1991 WL 8420

District Court of Appeal of Florida | Filed: Jan 31, 1991 | Docket: 64655949

Published

opinion. . § 893.13(l)(a)(l), Fla.Stat. (1987). . § 893.03(2)(a), Fla.Stat. (1987). . Lipscomb v. State

Pierremari v. State

564 So. 2d 633, 1990 Fla. App. LEXIS 5683, 1990 WL 108843

District Court of Appeal of Florida | Filed: Aug 2, 1990 | Docket: 64651908

Published

a violation of section 893.135(l)(b)3 and section 893.-03(2)(a), Florida Statutes (1989). We remand solely

Amado v. State

563 So. 2d 736, 1990 Fla. App. LEXIS 4091, 1990 WL 77234

District Court of Appeal of Florida | Filed: Jun 8, 1990 | Docket: 64651288

Published

Cocaine, a controlled substance described in F.S. 893.03(2)(a)4, or any mixture containing cocaine, in

Moore v. State

561 So. 2d 1273, 1990 Fla. App. LEXIS 3628, 1990 WL 67318

District Court of Appeal of Florida | Filed: May 23, 1990 | Docket: 64650817

Published

incarceration for possession of cocaine in violation of section 893.03, Florida Statutes (1987). We affirm in part

State v. Glenn

545 So. 2d 903, 1989 WL 27951

District Court of Appeal of Florida | Filed: Mar 29, 1989 | Docket: 1167941

Published

count of possession of cocaine in violation of section 893.03(2)(a)(4), Florida Statutes (1987). He pleaded

State v. Williams

539 So. 2d 575, 14 Fla. L. Weekly 615, 1989 Fla. App. LEXIS 1183, 1989 WL 20674

District Court of Appeal of Florida | Filed: Mar 9, 1989 | Docket: 64640875

Published

count of trafficking in cocaine in violation of section 893.03(2)(a), Florida Statutes (1987). The State appeals

McGee v. State

509 So. 2d 1102, 1987 Fla. LEXIS 2044, 12 Fla. L. Weekly 332

Supreme Court of Florida | Filed: Jul 9, 1987 | Docket: 64628390

Published

Stat. (1985). Cannabis is a controlled substance. § 893.03(l)(c)3, Fla.Stat. (1985). One who possesses 20

Dugan v. Dugan

504 So. 2d 1283, 11 Fla. L. Weekly 2526, 1986 Fla. App. LEXIS 11256

District Court of Appeal of Florida | Filed: Dec 3, 1986 | Docket: 64626206

Published

taken a Schedule I controlled substance under Section 893.03(l)(d), Florida Statutes, a felony under Section

Vessel Described as One 36 Foot Mirage, BHN CBD 36011M831 Displaying Florida Registration Numbers FL5182 Em v. State, Department of Natural Resources

487 So. 2d 1134, 11 Fla. L. Weekly 946, 1986 Fla. App. LEXIS 7446

District Court of Appeal of Florida | Filed: Apr 22, 1986 | Docket: 64619058

Published

substance as listed per § 893.13(l)(d)(2) and § 893.-03(l)(c). Section 932.702 makes it unlawful to transport

Lazarus v. Department of Professional Regulation

481 So. 2d 22, 10 Fla. L. Weekly 2674, 1985 Fla. App. LEXIS 17137

District Court of Appeal of Florida | Filed: Dec 3, 1985 | Docket: 64616554

Published

physical dependence § 893.03(2), Fla.Stat. (1981). Effective July 1, 1982, § 893.03 was amended and methaqualone

Olhausen v. Department of Business Regulation, Division of Alcoholic Beverages & Tobacco

472 So. 2d 514, 10 Fla. L. Weekly 1531, 1985 Fla. App. LEXIS 14917

District Court of Appeal of Florida | Filed: Jun 18, 1985 | Docket: 64613034

Published

Cocaine is a controlled substance pursuant to Section 893.03(2), Florida Statutes. 4. Based on the stipulation

Tuttle v. State

462 So. 2d 585, 1985 Fla. App. LEXIS 12140, 10 Fla. L. Weekly 256

District Court of Appeal of Florida | Filed: Jan 23, 1985 | Docket: 64609458

Published

893.13(l)(a)l, Florida Statutes (Supp.1982). See § 893.03(2)(a)4. Yet, the written judgment on the first

Santiago v. State

459 So. 2d 468, 9 Fla. L. Weekly 2479, 1984 Fla. App. LEXIS 16392

District Court of Appeal of Florida | Filed: Nov 28, 1984 | Docket: 64608294

Published

other Schedule I substances as set forth in Section 893.03, Florida Statutes. Appellant contends these

Mobley v. State

460 So. 2d 383, 9 Fla. L. Weekly 2266, 1984 Fla. App. LEXIS 15678

District Court of Appeal of Florida | Filed: Nov 1, 1984 | Docket: 64608607

Published

commonly known as Marijuana, in violation of Florida Statute 893.3(l)(a)(2) [893.-13(l)(a)(2)]_ (Emphasis supplied)

In re Forfeiture of a 1977 Datsun 280Z Automobile, Vin HLS30408139

448 So. 2d 78, 1984 Fla. App. LEXIS 12626

District Court of Appeal of Florida | Filed: Apr 11, 1984 | Docket: 64604070

Published

substance under section 893.03(l)(c), and dia-*79zepam is a controlled substance under section 893.03(4)(h).

Barber v. State

442 So. 2d 303, 1983 Fla. App. LEXIS 24327

District Court of Appeal of Florida | Filed: Dec 1, 1983 | Docket: 64601489

Published

13(l)(e), Florida Statutes (1981), rather than section 893.03(l)(c), Florida Statutes (1981). AFFIRMED AND

West v. State

439 So. 2d 907, 1983 Fla. App. LEXIS 21784

District Court of Appeal of Florida | Filed: Sep 21, 1983 | Docket: 64600273

Published

a sale of cocaine, a controlled substance. See § 893.03(2)(a)4. The affidavit did not say anything about

Parks v. State

437 So. 2d 790, 1983 Fla. App. LEXIS 21696

District Court of Appeal of Florida | Filed: Sep 16, 1983 | Docket: 64599503

Published

concur. . A controlled substance described in Section 893.03(l)(c)3, Florida Statutes (1981). . Section

Campbell v. State

423 So. 2d 608, 1982 Fla. App. LEXIS 21982

District Court of Appeal of Florida | Filed: Dec 21, 1982 | Docket: 64594015

Published

has no currently accepted medical use. See section 893.03 (l)(c), Fla.Stat. (1982). The facts of the

City of Tallahassee v. Forfeiture of One Yellow 1979 Fiat 2-Door Sedan Florida Tag No. FVN-467

414 So. 2d 1100, 1982 Fla. App. LEXIS 20082

District Court of Appeal of Florida | Filed: May 26, 1982 | Docket: 64590411

Published

Methaqualone which is a controlled substance under Section 893.03(2)(c)5., Florida Statutes (1980 Supp.). Under

State v. DeConingh

400 So. 2d 998, 1981 Fla. App. LEXIS 20205

District Court of Appeal of Florida | Filed: Jun 16, 1981 | Docket: 64583819

Published

is also a controlled substance pursuant to section 893.-03, Florida Statutes (1980). .I note that the

State v. Giordano

383 So. 2d 644, 1980 Fla. LEXIS 4225

Supreme Court of Florida | Filed: May 1, 1980 | Docket: 64576076

Published

CURIAM. The opinion of the trial court, finding section 893.03(1)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Ouellette

382 So. 2d 836, 1980 Fla. App. LEXIS 15971

District Court of Appeal of Florida | Filed: Apr 16, 1980 | Docket: 64575672

Published

marijuana was a controlled substance proscribed by Section 893.03(l)(c) Florida Statutes (1977), which the trial

Mason v. State

382 So. 2d 705, 1980 Fla. LEXIS 4197

Supreme Court of Florida | Filed: Apr 10, 1980 | Docket: 64575617

Published

to dismiss. The trial court’s finding that section 893.-03(l)(c)3, Florida Statutes (1978 Supp.), is constitutional

Carter v. State

382 So. 2d 302, 1980 Fla. LEXIS 4164

Supreme Court of Florida | Filed: Mar 13, 1980 | Docket: 64575524

Published

to dismiss. The trial court’s finding that section 893.-03(l)(c)3, Florida Statutes (1978 Supp.), is constitutional

State v. Brown

380 So. 2d 1040, 1980 Fla. LEXIS 4144

Supreme Court of Florida | Filed: Feb 28, 1980 | Docket: 64574817

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), to be

State v. Allen

380 So. 2d 1035, 1980 Fla. LEXIS 4146

Supreme Court of Florida | Filed: Feb 28, 1980 | Docket: 64574813

Published

CURIAM. The orders of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), to be

State v. Kronowit

380 So. 2d 1039, 1980 Fla. LEXIS 4145

Supreme Court of Florida | Filed: Feb 28, 1980 | Docket: 64574816

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), to be

State v. Bleyer

380 So. 2d 1036, 1980 Fla. LEXIS 4149

Supreme Court of Florida | Filed: Feb 28, 1980 | Docket: 64574814

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), to be

State v. Martin

377 So. 2d 1180, 1979 Fla. LEXIS 4905

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573352

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Anderson

377 So. 2d 1178, 1979 Fla. LEXIS 4909

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573347

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Lombardo

377 So. 2d 1178, 1979 Fla. LEXIS 4908

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573346

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Gainer

377 So. 2d 1173, 1979 Fla. LEXIS 4920

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573334

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Houchin

377 So. 2d 1173, 1979 Fla. LEXIS 4919

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573336

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Stafford

377 So. 2d 1174, 1979 Fla. LEXIS 4914

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573339

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (Í978 Supp.), unconstitutional

State v. Proctor

377 So. 2d 1177, 1979 Fla. LEXIS 4902

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573343

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Lyke

377 So. 2d 1171, 1979 Fla. LEXIS 4903

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573329

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Kimmer

377 So. 2d 1179, 1979 Fla. LEXIS 4907

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573349

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Nelson

377 So. 2d 1172, 1979 Fla. LEXIS 4921

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573333

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Feeney

377 So. 2d 1175, 1979 Fla. LEXIS 4923

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573341

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Nelson

377 So. 2d 1172, 1979 Fla. LEXIS 4921

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573333

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Rolandini

377 So. 2d 1174, 1979 Fla. LEXIS 4906

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573338

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. McManus

377 So. 2d 1172, 1979 Fla. LEXIS 4913

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573332

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Davanzo

377 So. 2d 1171, 1979 Fla. LEXIS 4924

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573331

Published

court granted a motion to dismiss and found section 893.03(l)(c)3, Florida Statutes (1978 Supp.), and

State v. Giuliano

377 So. 2d 1173, 1979 Fla. LEXIS 4922

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573335

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Sutton

377 So. 2d 1180, 1979 Fla. LEXIS 4904

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573351

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Townsend

377 So. 2d 1171, 1979 Fla. LEXIS 4918

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573330

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Castillo

377 So. 2d 1177, 1979 Fla. LEXIS 4915

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573345

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Ricci

377 So. 2d 1175, 1979 Fla. LEXIS 4901

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573340

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Riberio

377 So. 2d 1180, 1979 Fla. LEXIS 4917

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573353

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Roman

377 So. 2d 1179, 1979 Fla. LEXIS 4911

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573348

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Anthony

377 So. 2d 1177, 1979 Fla. LEXIS 4916

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573344

Published

CURIAM. The order of the trial court, finding section 893.03(l)(e), Florida Statutes (1978 Supp.), unconstitutional

State v. Billie

377 So. 2d 1179, 1979 Fla. LEXIS 4912

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573350

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

State v. Valsamidis

377 So. 2d 1174, 1979 Fla. LEXIS 4910

Supreme Court of Florida | Filed: Dec 13, 1979 | Docket: 64573337

Published

CURIAM. The order of the trial court, finding section 893.03(l)(c), Florida Statutes (1978 Supp.), unconstitutional

Leavitt v. State

369 So. 2d 993, 1979 Fla. App. LEXIS 14827

District Court of Appeal of Florida | Filed: Apr 17, 1979 | Docket: 64569706

Published

the definition of that term as proscribed by section 893.03(2)(a)4. Appellant contends that the trial court

Leavitt v. State

369 So. 2d 993, 1979 Fla. App. LEXIS 14827

District Court of Appeal of Florida | Filed: Apr 17, 1979 | Docket: 64569706

Published

the definition of that term as proscribed by section 893.03(2)(a)4. Appellant contends that the trial court

Dorsey v. State

367 So. 2d 692, 1979 Fla. App. LEXIS 14165

District Court of Appeal of Florida | Filed: Feb 9, 1979 | Docket: 64568611

Published

This is a Schedule I controlled substance under § 893.03(1 )(c) 17.

Dorsey v. State

367 So. 2d 692, 1979 Fla. App. LEXIS 14165

District Court of Appeal of Florida | Filed: Feb 9, 1979 | Docket: 64568611

Published

This is a Schedule I controlled substance under § 893.03(1 )(c) 17.

State v. Maier

366 So. 2d 501, 1979 Fla. App. LEXIS 14075

District Court of Appeal of Florida | Filed: Jan 19, 1979 | Docket: 64568053

Published

enforcement of that law,” i. e., Florida Statute § 893.03, which is the basis of the charges against appellee

Adams v. State

347 So. 2d 685, 1977 Fla. App. LEXIS 15767

District Court of Appeal of Florida | Filed: Jun 10, 1977 | Docket: 64559321

Published

(meperidine) is a controlled substance according to Section 893.-03(2)(b)(14), Florida Statutes (1975). A person

Lewis v. State

320 So. 2d 435, 1975 Fla. App. LEXIS 15436

District Court of Appeal of Florida | Filed: Oct 7, 1975 | Docket: 64549658

Published

State, Fla.App.1974, 296 So.2d 609 and Fla.Stat. § 893.03 F.S.A. Appellant secondly contends the trial court

Schneider v. State

314 So. 2d 622, 1975 Fla. App. LEXIS 13661

District Court of Appeal of Florida | Filed: Jun 18, 1975 | Docket: 64547388

Published

including hypnotic and somnifacient drugs. [See § 893.03, Schedule III, effective July 1, 1973.] The charge